| Year |
Citation |
Score |
| 2021 |
Koemans WJ, Larue RTHM, Kloft M, Ruisch JE, Compter I, Riedl RG, Heij LR, van Elmpt W, Berbée M, Buijsen J, Lambin P, Sosef MN, Grabsch HI. Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fields. Esophagus : Official Journal of the Japan Esophageal Society. 18: 100-110. PMID 32889674 DOI: 10.1007/S10388-020-00777-Y |
0.31 |
|
| 2020 |
Mowday AM, Copp JN, Syddall SP, Dubois LJ, Wang J, Lieuwes NG, Biemans R, Ashoorzadeh A, Abbattista MR, Williams EM, Guise CP, Lambin P, Ackerley DF, Smaill JB, Theys J, et al. nitroreductase NfsA is a reporter gene for non-invasive PET imaging in cancer gene therapy applications. Theranostics. 10: 10548-10562. PMID 32929365 DOI: 10.7150/Thno.46826 |
0.323 |
|
| 2020 |
Compter I, Eekers DBP, Hoeben A, Rouschop KMA, Reymen B, Ackermans L, Beckervordersantforth J, Bauer NJC, Anten MM, Wesseling P, Postma AA, De Ruysscher D, Lambin P. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial. Autophagy. PMID 32866424 DOI: 10.1080/15548627.2020.1816343 |
0.315 |
|
| 2020 |
Wu G, Woodruff HC, Shen J, Refaee T, Sanduleanu S, Abdalla I, Leijenaar RTH, Wang R, Xiong J, Bian J, Wu J, Lambin P. Diagnosis of Invasive Lung Adenocarcinoma Based on Chest CT Radiomic Features of Part-Solid Pulmonary Nodules: A Multicenter Study. Radiology. 192431. PMID 32840472 DOI: 10.1148/Radiol.2020192431 |
0.321 |
|
| 2020 |
Hamis S, Kohandel M, Dubois LJ, Yaromina A, Lambin P, Powathil GG. Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape. Plos Computational Biology. 16: e1008041. PMID 32745136 DOI: 10.1371/Journal.Pcbi.1008041 |
0.336 |
|
| 2020 |
Lieverse RIY, Van Limbergen EJ, Oberije CJG, Troost EGC, Hadrup SR, Dingemans AC, Hendriks LEL, Eckert F, Hiley C, Dooms C, Lievens Y, de Jong MC, Bussink J, Geets X, Valentini V, ... ... Lambin P, et al. Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial. Bmc Cancer. 20: 557. PMID 32539805 DOI: 10.1186/S12885-020-07055-1 |
0.336 |
|
| 2020 |
Sanduleanu S, Wiel AMAV, Lieverse RIY, Marcus D, Ibrahim A, Primakov S, Wu G, Theys J, Yaromina A, Dubois LJ, Lambin P. Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation Tracer. Cancers. 12. PMID 32455922 DOI: 10.3390/Cancers12051322 |
0.324 |
|
| 2020 |
Keek S, Sanduleanu S, Wesseling F, de Roest R, van den Brekel M, van der Heijden M, Vens C, Giuseppina C, Licitra L, Scheckenbach K, Vergeer M, Leemans CR, Brakenhoff RH, Nauta I, Cavalieri S, ... ... Lambin P, et al. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. Plos One. 15: e0232639. PMID 32442178 DOI: 10.1371/Journal.Pone.0232639 |
0.336 |
|
| 2020 |
Lambin P, Lieverse RIY, Eckert F, Marcus D, Oberije C, van der Wiel AMA, Guha C, Dubois LJ, Deasy JO. Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy. Seminars in Radiation Oncology. 30: 187-193. PMID 32381298 DOI: 10.1016/J.Semradonc.2019.12.003 |
0.489 |
|
| 2020 |
Sanduleanu S, Hamming-Vrieze O, Wesseling FWR, Even AJG, Hoebers FJ, Hoeben A, Vogel WV, Tesselaar MET, Parvin D, Bartelink H, Lambin P. [F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials. Clinical and Translational Radiation Oncology. 23: 9-15. PMID 32368624 DOI: 10.1016/J.Ctro.2020.04.004 |
0.311 |
|
| 2020 |
Bogowicz M, Jochems A, Deist TM, Tanadini-Lang S, Huang SH, Chan B, Waldron JN, Bratman S, O'Sullivan B, Riesterer O, Studer G, Unkelbach J, Barakat S, Brakenhoff RH, Nauta I, ... ... Lambin P, et al. Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer. Scientific Reports. 10: 4542. PMID 32161279 DOI: 10.1038/S41598-020-61297-4 |
0.318 |
|
| 2020 |
Rogers W, Thulasi Seetha S, Refaee TAG, Lieverse RIY, Granzier RWY, Ibrahim A, Keek SA, Sanduleanu S, Primakov SP, Beuque MPL, Marcus D, van der Wiel AMA, Zerka F, Oberije CJG, van Timmeren JE, ... ... Lambin P, et al. Radiomics: from qualitative to quantitative imaging. The British Journal of Radiology. 20190948. PMID 32101448 DOI: 10.1259/Bjr.20190948 |
0.335 |
|
| 2020 |
Reymen BJT, van Gisbergen MW, Even AJG, Zegers CML, Das M, Vegt E, Wildberger JE, Mottaghy FM, Yaromina A, Dubois LJ, van Elmpt W, De Ruysscher D, Lambin P. Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial. Clinical and Translational Radiation Oncology. 21: 49-55. PMID 32021913 DOI: 10.1016/J.Ctro.2019.12.002 |
0.358 |
|
| 2020 |
Refaee T, Wu G, Ibrahim A, Halilaj I, Leijenaar RTH, Rogers W, Gietema HA, Hendriks LEL, Lambin P, Woodruff HC. The Emerging Role of Radiomics in COPD and Lung Cancer. Respiration; International Review of Thoracic Diseases. 1-9. PMID 31991420 DOI: 10.1159/000505429 |
0.32 |
|
| 2020 |
Granzier R, Ibrahim A, Woodruff H, Nijnatten Tv, Samiei S, Boer Md, Heuts E, Hulsmans F, Lambin P, Lobbes M, Smidt M. Radiomics based on baseline DCE-MRI is predictive of tumor pathological complete response to neoadjuvant systemic therapy in breast cancer patients Ejso. 46. DOI: 10.1016/J.Ejso.2019.11.479 |
0.303 |
|
| 2019 |
Peerlings J, Compter I, Janssen F, Wiggins CJ, Postma AA, Mottaghy FM, Lambin P, Hoffmann AL. Characterizing geometrical accuracy in clinically optimised 7T and 3T magnetic resonance images for high-precision radiation treatment of brain tumours. Physics and Imaging in Radiation Oncology. 9: 35-42. PMID 33458423 DOI: 10.1016/J.Phro.2018.12.001 |
0.321 |
|
| 2019 |
van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Frontiers in Oncology. 9: 1470. PMID 31998639 DOI: 10.3389/Fonc.2019.01470 |
0.331 |
|
| 2019 |
Meaney C, Powathil GG, Yaromina A, Dubois LJ, Lambin P, Kohandel M. Role of hypoxia-activated prodrugs in combination with radiation therapy: An approach. Mathematical Biosciences and Engineering : Mbe. 16: 6257-6273. PMID 31698561 DOI: 10.3934/Mbe.2019312 |
0.325 |
|
| 2019 |
Ibrahim A, Vallières M, Woodruff H, Primakov S, Beheshti M, Keek S, Refaee T, Sanduleanu S, Walsh S, Morin O, Lambin P, Hustinx R, Mottaghy FM. Radiomics Analysis for Clinical Decision Support in Nuclear Medicine. Seminars in Nuclear Medicine. 49: 438-449. PMID 31470936 DOI: 10.1053/J.Semnuclmed.2019.06.005 |
0.325 |
|
| 2019 |
Spiegelberg L, van Hoof SJ, Biemans R, Lieuwes NG, Marcus D, Niemans R, Theys J, Yaromina A, Lambin P, Verhaegen F, Dubois LJ. Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 141: 247-255. PMID 31431383 DOI: 10.1016/J.Radonc.2019.06.034 |
0.309 |
|
| 2019 |
van Timmeren JE, Carvalho S, Leijenaar RTH, Troost EGC, van Elmpt W, de Ruysscher D, Muratet JP, Denis F, Schimek-Jasch T, Nestle U, Jochems A, Woodruff HC, Oberije C, Lambin P. Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics. Plos One. 14: e0217536. PMID 31158263 DOI: 10.1371/Journal.Pone.0217536 |
0.343 |
|
| 2019 |
Salgado R, Solit DB, Rimm DL, Bogaerts J, Canetta R, Lively T, Lyerly K, Span PN, Bateman-House A, Makady A, Bergmann L, Nagai S, Smith C, Robson M, Savage M, ... ... Lambin P, et al. Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology. European Journal of Cancer (Oxford, England : 1990). PMID 31060925 DOI: 10.1016/J.Ejca.2019.03.025 |
0.33 |
|
| 2019 |
van Timmeren JE, van Elmpt W, Leijenaar RTH, Reymen B, Monshouwer R, Bussink J, Paelinck L, Bogaert E, De Wagter C, Elhaseen E, Lievens Y, Hansen O, Brink C, Lambin P. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 136: 78-85. PMID 31015133 DOI: 10.1016/J.Radonc.2019.03.032 |
0.378 |
|
| 2019 |
Kjellsson Lindblom E, Ureba A, Dasu A, Wersäll P, Even AJG, van Elmpt W, Lambin P, Toma-Dasu I. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation. Medical Physics. 46: 2512-2521. PMID 30924937 DOI: 10.1002/Mp.13514 |
0.351 |
|
| 2019 |
Peerlings J, Woodruff HC, Winfield JM, Ibrahim A, Van Beers BE, Heerschap A, Jackson A, Wildberger JE, Mottaghy FM, DeSouza NM, Lambin P. Stability of radiomics features in apparent diffusion coefficient maps from a multi-centre test-retest trial. Scientific Reports. 9: 4800. PMID 30886309 DOI: 10.1038/S41598-019-41344-5 |
0.315 |
|
| 2019 |
Spiegelberg L, Houben R, Niemans R, de Ruysscher D, Yaromina A, Theys J, Guise CP, Smaill JB, Patterson AV, Lambin P, Dubois LJ. Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials. Clinical and Translational Radiation Oncology. 15: 62-69. PMID 30734002 DOI: 10.1016/J.Ctro.2019.01.005 |
0.338 |
|
| 2019 |
Petersen JF, Berlanga A, Stuiver MM, Hamming-Vrieze O, Hoebers F, Lambin P, van den Brekel MWM. Improving decision making in larynx cancer by developing a decision aid: A mixed methods approach. The Laryngoscope. 129: 2733-2739. PMID 30663068 DOI: 10.1002/Lary.27800 |
0.331 |
|
| 2019 |
Rizzo S, Raimondi S, de Jong EEC, van Elmpt W, De Piano F, Petrella F, Bagnardi V, Jochems A, Bellomi M, Dingemans AM, Lambin P. Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation. European Journal of Radiology. 110: 148-155. PMID 30599853 DOI: 10.1016/J.Ejrad.2018.11.032 |
0.33 |
|
| 2019 |
Eekers DBP, Roelofs E, Cubillos-Mesías M, Niël C, Smeenk RJ, Hoeben A, Minken AWH, Granzier M, Janssens GO, Kaanders JHAM, Lambin P, Troost EGC. Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial. Acta Oncologica (Stockholm, Sweden). 58: 57-65. PMID 30474448 DOI: 10.1080/0284186X.2018.1529424 |
0.32 |
|
| 2018 |
Klaassen R, Larue RTHM, Mearadji B, van der Woude SO, Stoker J, Lambin P, van Laarhoven HWM. Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients. Plos One. 13: e0207362. PMID 30440002 DOI: 10.1371/Journal.Pone.0207362 |
0.312 |
|
| 2018 |
Haider S, Yao CQ, Sabine VS, Grzadkowski M, Stimper V, Starmans MHW, Wang J, Nguyen F, Moon NC, Lin X, Drake C, Crozier CA, Brookes CL, van de Velde CJH, Hasenburg A, ... ... Lambin P, et al. Pathway-based subnetworks enable cross-disease biomarker discovery. Nature Communications. 9: 4746. PMID 30420699 DOI: 10.1038/S41467-018-07021-3 |
0.317 |
|
| 2018 |
de Jong EEC, van Elmpt W, Rizzo S, Colarieti A, Spitaleri G, Leijenaar RTH, Jochems A, Hendriks LEL, Troost EGC, Reymen B, Dingemans AC, Lambin P. Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 124: 6-11. PMID 30268481 DOI: 10.1016/J.Lungcan.2018.07.023 |
0.361 |
|
| 2018 |
Morin O, Vallières M, Jochems A, Woodruff HC, Valdes G, Braunstein SE, Wildberger JE, Villanueva-Meyer JE, Kearney V, Yom SS, Solberg TD, Lambin P. A Deep Look into the Future of Quantitative Imaging in Oncology: A Statement of Working Principles and Proposal for Change. International Journal of Radiation Oncology, Biology, Physics. PMID 30170101 DOI: 10.1016/J.Ijrobp.2018.08.032 |
0.36 |
|
| 2018 |
Larue RTHM, Klaassen R, Jochems A, Leijenaar RTH, Hulshof MCCM, van Berge Henegouwen MI, Schreurs WMJ, Sosef MN, van Elmpt W, van Laarhoven HWM, Lambin P. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer. Acta Oncologica (Stockholm, Sweden). 57: 1475-1481. PMID 30067421 DOI: 10.1080/0284186X.2018.1486039 |
0.372 |
|
| 2018 |
Press RH, Shu HG, Shim H, Mountz JM, Kurland BF, Wahl RL, Jones EF, Hylton NM, Gerstner ER, Nordstrom RJ, Henderson L, Kurdziel KA, Vikram B, Jacobs MA, Holdhoff M, ... ... Lambin P, et al. The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective. International Journal of Radiation Oncology, Biology, Physics. PMID 29966725 DOI: 10.1016/J.Ijrobp.2018.06.023 |
0.382 |
|
| 2018 |
van Wijk Y, Vanneste BGL, Jochems A, Walsh S, Oberije CJ, Pinkawa M, Ramaekers BLT, Vega A, Lambin P. Development of an isotoxic decision support system integrating genetic markers of toxicity for the implantation of a rectum spacer. Acta Oncologica (Stockholm, Sweden). 1-7. PMID 29952681 DOI: 10.1080/0284186X.2018.1484156 |
0.309 |
|
| 2018 |
Dinapoli N, Barbaro B, Gatta R, Chiloiro G, Casà C, Masciocchi C, Damiani A, Boldrini L, Gambacorta MA, Dezio M, Mattiucci GC, Balducci M, van Soest J, Dekker A, Lambin P, et al. Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29891200 DOI: 10.1016/J.Ijrobp.2018.04.065 |
0.303 |
|
| 2018 |
Hartgerink D, van der Heijden B, De Ruysscher D, Postma A, Ackermans L, Hoeben A, Anten M, Lambin P, Terhaag K, Jochems A, Dekker A, Schoenmaekers J, Hendriks L, Zindler J. Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions. Frontiers in Oncology. 8: 154. PMID 29868476 DOI: 10.3389/Fonc.2018.00154 |
0.375 |
|
| 2018 |
Jaffray DA, Das S, Jacobs PM, Jeraj R, Lambin P. How Advances in Imaging Will Affect Precision Radiation Oncology. International Journal of Radiation Oncology, Biology, Physics. 101: 292-298. PMID 29726358 DOI: 10.1016/J.Ijrobp.2018.01.047 |
0.378 |
|
| 2018 |
Apeke S, Gaubert L, Boussion N, Lambin P, Visvikis D, Rodin V, Redou P. Multi-Scale Modeling and Oxygen Impact on Tumor Temporal Evolution: Application on Rectal Cancer During Radiotherapy. Ieee Transactions On Medical Imaging. 37: 871-880. PMID 29610067 DOI: 10.1109/Tmi.2017.2771379 |
0.318 |
|
| 2018 |
Eekers DBP, In 't Ven L, Deprez S, Jacobi L, Roelofs E, Hoeben A, Lambin P, de Ruysscher D, Troost EGC. The posterior cerebellum, a new organ at risk? Clinical and Translational Radiation Oncology. 8: 22-26. PMID 29594239 DOI: 10.1016/J.Ctro.2017.11.010 |
0.311 |
|
| 2018 |
Lazzeroni M, Uhrdin J, Carvalho S, Elmpt Wv, Lambin P, Dasu A, Wersäll P, Toma-Dasu I. Evaluation of third treatment week as temporal window for assessing responsiveness on repeated FDG-PET-CT scans in Non-Small Cell Lung Cancer patients Physica Medica. 46: 45-51. PMID 29519408 DOI: 10.1016/J.Ejmp.2018.01.012 |
0.336 |
|
| 2018 |
Carvalho S, Leijenaar RTH, Troost EGC, van Timmeren JE, Oberije C, van Elmpt W, de Geus-Oei LF, Bussink J, Lambin P. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study. Plos One. 13: e0192859. PMID 29494598 DOI: 10.1371/Journal.Pone.0192859 |
0.335 |
|
| 2018 |
Walsh S, Roelofs E, Kuess P, van Wijk Y, Vanneste B, Dekker A, Lambin P, Jones B, Georg D, Verhaegen F. Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability. Cancers. 10. PMID 29463018 DOI: 10.3390/Cancers10020055 |
0.371 |
|
| 2018 |
Salem A, Asselin MC, Reymen B, Jackson A, Lambin P, West CML, O'Connor JPB, Faivre-Finn C. Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome. Journal of the National Cancer Institute. 110. PMID 28922791 DOI: 10.1093/Jnci/Djx160 |
0.352 |
|
| 2018 |
thiolloy s, Deschoemaeker S, Ongenae N, Gilissen J, Dubois L, Yaromina A, Ashoorzadeh A, Smaill J, Patterson A, Lambin P, Heyerick A. Abstract 4959: CP-506, a next generation hypoxia-activated prodrug, as promising novel anti-cancer therapeutic Cancer Research. 78: 4959-4959. DOI: 10.1158/1538-7445.Am2018-4959 |
0.355 |
|
| 2018 |
Lambin P. [I232] Radiomics: Transforming standard imaging into mineable data related to biology Physica Medica. 52: 87. DOI: 10.1016/J.Ejmp.2018.06.304 |
0.306 |
|
| 2017 |
Deist TM, Jochems A, van Soest J, Nalbantov G, Oberije C, Walsh S, Eble M, Bulens P, Coucke P, Dries W, Dekker A, Lambin P. Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care: euroCAT. Clinical and Translational Radiation Oncology. 4: 24-31. PMID 29594204 DOI: 10.1016/J.Ctro.2016.12.004 |
0.306 |
|
| 2017 |
Cusumano D, Dinapoli N, Boldrini L, Chiloiro G, Gatta R, Masciocchi C, Lenkowicz J, Casà C, Damiani A, Azario L, Van Soest J, Dekker A, Lambin P, De Spirito M, Valentini V. Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer. La Radiologia Medica. PMID 29230678 DOI: 10.1007/S11547-017-0838-3 |
0.324 |
|
| 2017 |
Tunali I, Stringfield O, Guvenis A, Wang H, Liu Y, Balagurunathan Y, Lambin P, Gillies RJ, Schabath MB. Radial gradient and radial deviation radiomic features from pre-surgical CT scans are associated with survival among lung adenocarcinoma patients. Oncotarget. 8: 96013-96026. PMID 29221183 DOI: 10.18632/Oncotarget.21629 |
0.306 |
|
| 2017 |
Ureba A, Lindblom E, Dasu A, Uhrdin J, Even AJG, Elmpt Wv, Lambin P, Wersäll P, Toma-Dasu I. Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription. Acta Oncologica. 57: 485-490. PMID 29141489 DOI: 10.1080/0284186X.2017.1400177 |
0.338 |
|
| 2017 |
Even AJG, Reymen B, La Fontaine MD, Das M, Mottaghy FM, Belderbos JSA, De Ruysscher D, Lambin P, van Elmpt W. Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29122363 DOI: 10.1016/J.Radonc.2017.09.041 |
0.33 |
|
| 2017 |
Bogowicz M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, Pruschy M, Studer G, Unkelbach J, Guckenberger M, Konukoglu E, Lambin P. Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models Radiotherapy and Oncology. 125: 385-391. PMID 29122358 DOI: 10.1016/J.Radonc.2017.10.023 |
0.308 |
|
| 2017 |
Bongers ML, de Ruysscher D, Oberije C, Lambin P, Uyl-de Groot CA, Belderbos J, Coupé VMH. MODEL-BASED COST-EFFECTIVENESS OF CONVENTIONAL AND INNOVATIVE CHEMO-RADIATION IN LUNG CANCER. International Journal of Technology Assessment in Health Care. 1-10. PMID 29122046 DOI: 10.1017/S0266462317000939 |
0.355 |
|
| 2017 |
Jochems A, Deist TM, El Naqa I, Kessler M, Mayo C, Reeves J, Jolly S, Matuszak M, Ten Haken R, van Soest J, Oberije C, Faivre-Finn C, Price G, de Ruysscher D, Lambin P, et al. Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries. International Journal of Radiation Oncology, Biology, Physics. 99: 344-352. PMID 28871984 DOI: 10.1016/J.Ijrobp.2017.04.021 |
0.332 |
|
| 2017 |
Even AJG, Reymen B, La Fontaine MD, Das M, Jochems A, Mottaghy FM, Belderbos JSA, De Ruysscher D, Lambin P, van Elmpt W. Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT. Acta Oncologica (Stockholm, Sweden). 1-6. PMID 28840770 DOI: 10.1080/0284186X.2017.1349332 |
0.345 |
|
| 2017 |
Timmeren JEv, Leijenaar RTH, Elmpt Wv, Reymen B, Lambin P. Feature selection methodology for longitudinal cone-beam CT radiomics Acta Oncologica. 56: 1537-1543. PMID 28826307 DOI: 10.1080/0284186X.2017.1350285 |
0.309 |
|
| 2017 |
Larue RTHM, Voorde LVD, Timmeren JEv, Leijenaar RTH, Berbée M, Sosef MN, Schreurs WMJ, Elmpt Wv, Lambin P. 4DCT imaging to assess radiomics feature stability: An investigation for thoracic cancers. Radiotherapy and Oncology. 125: 147-153. PMID 28797700 DOI: 10.1016/J.Radonc.2017.07.023 |
0.332 |
|
| 2017 |
Zindler JD, Bruynzeel AME, Eekers DBP, Hurkmans CW, Swinnen A, Lambin P. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial Bmc Cancer. 17: 500-500. PMID 28743240 DOI: 10.1186/S12885-017-3494-Z |
0.306 |
|
| 2017 |
Grossmann P, Stringfield O, El-Hachem N, Bui MM, Rios Velazquez E, Parmar C, Leijenaar RT, Haibe-Kains B, Lambin P, Gillies R, Aerts HJ. Defining the biological basis of radiomic phenotypes in lung cancer. Elife. 6. PMID 28731408 DOI: 10.7554/Elife.23421 |
0.336 |
|
| 2017 |
Peerlings J, Van De Voorde L, Mitea C, Larue R, Yaromina A, Sandeleanu S, Spiegelberg L, Dubois L, Lambin P, Mottaghy FM. Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review. Methods (San Diego, Calif.). PMID 28705470 DOI: 10.1016/J.Ymeth.2017.07.002 |
0.302 |
|
| 2017 |
Ou D, Blanchard P, Rosellini S, Levy A, Nguyen F, Leijenaar RTH, Garberis I, Gorphe P, Bidault F, Ferté C, Robert C, Casiraghi O, Scoazec JY, Lambin P, Temam S, et al. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status. Oral Oncology. 71: 150-155. PMID 28688683 DOI: 10.1016/J.Oraloncology.2017.06.015 |
0.314 |
|
| 2017 |
Deist TM, Yang P, Oberije C, Allen PK, van Wijk Y, Gomez DR, Xu T, Mohan R, Hahn SM, Lambin P, Liao Z. Dosimetric Analysis of Randomized Proton and Photon Plans with Respect to Radiation Toxicity: The Importance of High Dose Regions in Lung and Esophagus. International Journal of Radiation Oncology, Biology, Physics. 98: 246. PMID 28587033 DOI: 10.1016/J.Ijrobp.2017.01.187 |
0.309 |
|
| 2017 |
van Timmeren JE, Leijenaar RTH, van Elmpt W, Reymen B, Oberije C, Monshouwer R, Bussink J, Brink C, Hansen O, Lambin P. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28506693 DOI: 10.1016/J.Radonc.2017.04.016 |
0.343 |
|
| 2017 |
Azria D, Lapierre A, Gourgou S, De Ruysscher D, Colinge J, Lambin P, Brengues M, Ward T, Bentzen SM, Thierens H, Rancati T, Talbot CJ, Vega A, Kerns SL, Andreassen CN, et al. Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. Frontiers in Oncology. 7: 83. PMID 28497027 DOI: 10.3389/Fonc.2017.00083 |
0.318 |
|
| 2017 |
Lindblom E, Dasu A, Uhrdin J, Even AJG, Elmpt Wv, Lambin P, Wersäll P, Toma-Dasu I. Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy - the influence of the choice of the reference region and conversion function. Acta Oncologica. 56: 819-825. PMID 28464740 DOI: 10.1080/0284186X.2017.1293289 |
0.312 |
|
| 2017 |
Zindler JD, Jochems A, Lagerwaard FJ, Beumer R, Troost EG, Eekers DB, Compter I, van der Toorn PP, Essers M, Oei B, Hurkmans CW, Bruynzeel AM, Bosmans G, Swinnen A, Leijenaar RT, ... Lambin P, et al. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28237400 DOI: 10.1016/J.Radonc.2017.02.006 |
0.304 |
|
| 2017 |
Glatzer M, Putora PM, Ruysscher DD, Lambin P, Berlanga A. Hang Doctor: A Smartphone App to Learn and Improve Knowledge of TNM Classification in Non-Small Cell Lung Cancer (NSCLC) European Respiratory Journal. 50. DOI: 10.1183/1393003.Congress-2017.Pa2772 |
0.336 |
|
| 2016 |
Vanneste BG, Van Limbergen EJ, van Lin EN, van Roermund JG, Lambin P. Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know? Biomed Research International. 2016: 6829875. PMID 28116302 DOI: 10.1155/2016/6829875 |
0.357 |
|
| 2016 |
van Loon J, Even AJ, Aerts HJ, Öllers M, Hoebers F, van Elmpt W, Dubois L, Dingemans AC, Lalisang RI, Kempers P, Brans B, Winnepenninckx V, Speel EJ, Thunnissen E, Smits KM, ... ... Lambin P, et al. PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28012793 DOI: 10.1016/J.Radonc.2016.11.020 |
0.339 |
|
| 2016 |
Even AJ, Hamming-Vrieze O, van Elmpt W, Winnepenninckx VJ, Heukelom J, Tesselaar ME, Vogel WV, Hoeben A, Zegers CM, Vugts DJ, van Dongen GA, Bartelink H, Mottaghy FM, Hoebers F, Lambin P. Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach. Oncotarget. PMID 27965472 DOI: 10.18632/Oncotarget.13910 |
0.346 |
|
| 2016 |
Verwer EE, Zegers CM, van Elmpt W, Wierts R, Windhorst AD, Mottaghy FM, Lambin P, Boellaard R. Pharmacokinetic modeling of a novel hypoxia PET tracer [(18)F]HX4 in patients with non-small cell lung cancer. Ejnmmi Physics. 3: 30. PMID 27957730 DOI: 10.1186/S40658-016-0167-Y |
0.325 |
|
| 2016 |
Martinussen HM, Reymen B, Wanders R, Troost EG, Dingemans AC, Öllers M, Houben R, De Ruysscher D, Lambin P, van Baardwijk A. Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27884510 DOI: 10.1016/J.Radonc.2016.10.001 |
0.346 |
|
| 2016 |
O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, ... ... Lambin P, et al. Imaging biomarker roadmap for cancer studies. Nature Reviews. Clinical Oncology. PMID 27725679 DOI: 10.1038/Nrclinonc.2016.162 |
0.32 |
|
| 2016 |
de Jong E, van Elmpt W, Leijenaar RT, Carvalho S, Troost EG, Hendriks LE, Dingemans AM, Lambin P. Prospective Validation of a Prognostic Computed Tomography-Based Radiomic Signature in Stage IV Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S192. PMID 27675755 DOI: 10.1016/J.Ijrobp.2016.06.480 |
0.331 |
|
| 2016 |
Eekers DB, Roelofs E, Jelen U, Kirk M, Granzier M, Ammazzalorso F, Ahn PH, Janssens GO, Hoebers FJ, Friedmann T, Solberg T, Walsh S, Troost EG, Kaanders JH, Lambin P. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27639891 DOI: 10.1016/J.Radonc.2016.08.020 |
0.308 |
|
| 2016 |
Larue RT, Van De Voorde L, Berbée M, van Elmpt WJ, Dubois LJ, Panth KM, Peeters SG, Claessens A, Schreurs WM, Nap M, Warmerdam FA, Erdkamp FL, Sosef MN, Lambin P. A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients. Bmc Cancer. 16: 644. PMID 27535748 DOI: 10.1186/S12885-016-2709-Z |
0.339 |
|
| 2016 |
Mowday AM, Guise CP, Ackerley DF, Minton NP, Lambin P, Dubois LJ, Theys J, Smaill JB, Patterson AV. Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress. Cancers. 8. PMID 27367731 DOI: 10.3390/Cancers8070063 |
0.35 |
|
| 2016 |
Zegers CM, Hoebers FJ, van Elmpt W, Bons JA, Öllers MC, Troost EG, Eekers D, Balmaekers L, Arts-Pechtold M, Mottaghy FM, Lambin P. Evaluation of tumour hypoxia during radiotherapy using [(18)F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27251643 DOI: 10.1007/S00259-016-3429-Y |
0.317 |
|
| 2016 |
Carvalho S, Troost EGC, Bons J, Menheere P, Lambin P, Oberije C. Data from: Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer – a survival model with external validation Radiotherapy and Oncology. 119: 487-494. PMID 27139126 DOI: 10.1016/J.Radonc.2016.04.024 |
0.32 |
|
| 2016 |
van Kuijk SJ, Yaromina A, Houben R, Niemans R, Lambin P, Dubois LJ. Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis. Frontiers in Oncology. 6: 69. PMID 27066453 DOI: 10.3389/Fonc.2016.00069 |
0.31 |
|
| 2016 |
Wu W, Parmar C, Grossmann P, Quackenbush J, Lambin P, Bussink J, Mak R, Aerts HJ. Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology. Frontiers in Oncology. 6: 71. PMID 27064691 DOI: 10.3389/Fonc.2016.00071 |
0.344 |
|
| 2016 |
Cheng Q, Roelofs E, Ramaekers BL, Eekers D, van Soest J, Lustberg T, Hendriks T, Hoebers F, van der Laan HP, Korevaar EW, Dekker A, Langendijk JA, Lambin P. Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer - Comparison of dose, toxicity and cost-effectiveness. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26924342 DOI: 10.1016/J.Radonc.2015.12.029 |
0.304 |
|
| 2016 |
Walsh S, Roelofs E, Kuess P, Lambin P, Jones B, Georg D, Verhaegen F. A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy. Medical Physics. 43: 734. PMID 26843237 DOI: 10.1118/1.4939260 |
0.334 |
|
| 2016 |
Lambin P, Zindler J, Vanneste BG, De Voorde LV, Eekers D, Compter I, Panth KM, Peerlings J, Larue RT, Deist TM, Jochems A, Lustberg T, van Soest J, de Jong EE, Even AJ, et al. Decision support systems for personalized and participative radiation oncology. Advanced Drug Delivery Reviews. PMID 26774327 DOI: 10.1016/J.Addr.2016.01.006 |
0.303 |
|
| 2016 |
Zindler JD, Thomas CR, Hahn SM, Hoffmann AL, Troost EG, Lambin P. Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription. Journal of the National Cancer Institute. 108. PMID 26476075 DOI: 10.1093/Jnci/Djv305 |
0.322 |
|
| 2016 |
Bongers ML, Ruysscher Dd, Oberije C, Lambin P, Groot CAU, Coupé VMH. Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity Medical Decision Making. 36: 86-100. PMID 25732723 DOI: 10.1177/0272989X15574500 |
0.337 |
|
| 2016 |
Valdagni R, Appanvel A, Botma A, Webb A, Azria D, Burr T, Chang-Claude J, Davidson S, Elliot RM, Gutierrez-Enríquez S, Johnson K, Lambin P, Rancati T, Rosenstein B, Ruysscher DD, et al. The REQUITE Project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors. Journal of Clinical Oncology. 34: 85-85. DOI: 10.1200/Jco.2016.34.2_Suppl.85 |
0.308 |
|
| 2016 |
Timmeren JEv, Leijenaar RTH, Elmpt Wv, Lambin P. Interchangeability of a Radiomic Signature Between Conventional and Weekly Cone Beam Computed Tomography Allowing Response Prediction in Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 96. DOI: 10.1016/J.Ijrobp.2016.06.482 |
0.313 |
|
| 2015 |
Parmar C, Grossmann P, Rietveld D, Rietbergen MM, Lambin P, Aerts HJWL. Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer Frontiers in Oncology. 5: 272-272. PMID 26697407 DOI: 10.3389/Fonc.2015.00272 |
0.311 |
|
| 2015 |
Sharifi H, van Elmpt W, Oberije C, Nalbantov G, Das M, Öllers M, Lambin P, Dingmans AC, De Ruysscher D. Quantification of CT-assessed radiation-induced lung damage in lung cancer patients treated with or without chemotherapy and cetuximab. Acta Oncologica (Stockholm, Sweden). 1-7. PMID 26399389 DOI: 10.3109/0284186X.2015.1080856 |
0.371 |
|
| 2015 |
Van De Voorde L, Larue R, Persoon L, Öllers M, Nijsten S, Bosmans G, Berbée M, Swinnen A, van Elmpt W, Vanneste B, Verhaegen F, Lambin P. The influence of gastric filling instructions on dose delivery in patients with oesophageal cancer: A prospective study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26364885 DOI: 10.1016/J.Radonc.2015.09.006 |
0.331 |
|
| 2015 |
van Elmpt W, Zegers CM, Reymen B, Even AJ, Dingemans AC, Oellers M, Wildberger JE, Mottaghy FM, Das M, Troost EG, Lambin P. Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26338178 DOI: 10.1007/S00259-015-3169-4 |
0.354 |
|
| 2015 |
Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJWL. Machine Learning methods for Quantitative Radiomic Biomarkers Scientific Reports. 5: 13087-13087. PMID 26278466 DOI: 10.1038/Srep13087 |
0.301 |
|
| 2015 |
Leijenaar RT, Carvalho S, Hoebers FJ, Aerts HJ, van Elmpt WJ, Huang SH, Chan B, Waldron JN, O'sullivan B, Lambin P. External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncologica (Stockholm, Sweden). 1-7. PMID 26264429 DOI: 10.3109/0284186X.2015.1061214 |
0.369 |
|
| 2015 |
Buijsen J, van den Bogaard J, Jutten B, Belgers E, Sosef M, Leijtens JW, Beets GL, Jansen RL, Riedl RG, Clarijs R, Lammering G, Lambin P. A phase I-II study on the combination of rapamycin and short course radiotherapy in rectal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 116: 214-20. PMID 26253949 DOI: 10.1016/J.Radonc.2015.07.039 |
0.365 |
|
| 2015 |
Leijenaar RT, Nalbantov G, Carvalho S, van Elmpt WJ, Troost EG, Boellaard R, Aerts HJ, Gillies RJ, Lambin P. The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis. Scientific Reports. 5: 11075. PMID 26242464 DOI: 10.1038/Srep11075 |
0.319 |
|
| 2015 |
Even AJ, van der Stoep J, Zegers CM, Reymen B, Troost EG, Lambin P, van Elmpt W. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 116: 281-6. PMID 26238010 DOI: 10.1016/J.Radonc.2015.07.013 |
0.364 |
|
| 2015 |
Panth KM, Leijenaar RT, Carvalho S, Lieuwes NG, Yaromina A, Dubois L, Lambin P. Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 116: 462-6. PMID 26163091 DOI: 10.1016/J.Radonc.2015.06.013 |
0.307 |
|
| 2015 |
Zegers CM, van Elmpt W, Szardenings K, Kolb H, Waxman A, Subramaniam RM, Moon DH, Brunetti JC, Srinivas SM, Lambin P, Chien D. Repeatability of hypoxia PET imaging using [(18)F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1840-9. PMID 26136164 DOI: 10.1007/S00259-015-3100-Z |
0.351 |
|
| 2015 |
Van De Voorde L, Janssen L, Larue R, Houben R, Buijsen J, Sosef M, Vanneste B, Schraepen MC, Berbée M, Lambin P. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer? European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 26091848 DOI: 10.1016/J.Ejso.2015.05.012 |
0.322 |
|
| 2015 |
Theys J, Lambin P. Clostridium to treat cancer: dream or reality? Annals of Translational Medicine. 3: 21. PMID 26046067 DOI: 10.3978/J.Issn.2305-5839.2015.03.39 |
0.333 |
|
| 2015 |
Oberije C, De Ruysscher D, Houben R, van de Heuvel M, Uyterlinde W, Deasy JO, Belderbos J, Dingemans AM, Rimner A, Din S, Lambin P. A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients. International Journal of Radiation Oncology, Biology, Physics. 92: 935-44. PMID 25936599 DOI: 10.1016/J.Ijrobp.2015.02.048 |
0.51 |
|
| 2015 |
Trani D, Reniers B, Persoon L, Podesta M, Nalbantov G, Leijenaar RT, Granzier M, Yaromina A, Dubois L, Verhaegen F, Lambin P. What level of accuracy is achievable for preclinical dose painting studies on a clinical irradiation platform? Radiation Research. 183: 501-10. PMID 25897556 DOI: 10.1667/Rr13933.1 |
0.369 |
|
| 2015 |
Peeters SG, Zegers CM, Biemans R, Lieuwes NG, van Stiphout RG, Yaromina A, Sun JD, Hart CP, Windhorst AD, van Elmpt W, Dubois LJ, Lambin P. TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2984-92. PMID 25805800 DOI: 10.1158/1078-0432.Ccr-15-0018 |
0.32 |
|
| 2015 |
Bongers ML, Coupé VMH, Ruysscher DD, Oberije C, Lambin P, Groot CAU. Individualized Positron Emission Tomography-Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy: A Model-Based Evaluation International Journal of Radiation Oncology Biology Physics. 91: 857-865. PMID 25752401 DOI: 10.1016/J.Ijrobp.2014.12.012 |
0.322 |
|
| 2015 |
Coroller TP, Grossmann P, Hou Y, Rios Velazquez E, Leijenaar RT, Hermann G, Lambin P, Haibe-Kains B, Mak RH, Aerts HJ. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 114: 345-50. PMID 25746350 DOI: 10.1016/J.Radonc.2015.02.015 |
0.338 |
|
| 2015 |
Grove O, Berglund AE, Schabath MB, Aerts HJ, Dekker A, Wang H, Velazquez ER, Lambin P, Gu Y, Balagurunathan Y, Eikman E, Gatenby RA, Eschrich S, Gillies RJ. Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma. Plos One. 10: e0118261. PMID 25739030 DOI: 10.1371/Journal.Pone.0118261 |
0.335 |
|
| 2015 |
Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rödel C, Sainato A, Sauer R, Minsky BD, ... ... Lambin P, et al. Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 114: 302-9. PMID 25716096 DOI: 10.1016/J.Radonc.2015.02.001 |
0.332 |
|
| 2015 |
Fontanarosa D, Witte M, Meijer G, Shakirin G, Steenhuijsen J, Schuring D, van Herk M, Lambin P. Probabilistic evaluation of target dose deterioration in dose painting by numbers for stage II/III lung cancer. Practical Radiation Oncology. 5: e375-82. PMID 25680996 DOI: 10.1016/J.Prro.2015.01.001 |
0.358 |
|
| 2015 |
Creutzberg CL, Stiphout RGPMv, Nout RA, Lutgens LCHW, Jürgenliemk-Schulz IM, Jobsen JJ, Smit VTHBM, Lambin P. Nomograms for Prediction of Outcome With or Without Adjuvant Radiation Therapy for Patients With Endometrial Cancer: A Pooled Analysis of PORTEC-1 and PORTEC-2 Trials International Journal of Radiation Oncology Biology Physics. 91: 530-539. PMID 25680597 DOI: 10.1016/J.Ijrobp.2014.11.022 |
0.363 |
|
| 2015 |
Toma-Dasu I, Uhrdin J, Lazzeroni M, Carvalho S, Elmpt Wv, Lambin P, Dasu A. Evaluating Tumor Response of Non-Small Cell Lung Cancer Patients With 18F-Fludeoxyglucose Positron Emission Tomography: Potential for Treatment Individualization International Journal of Radiation Oncology Biology Physics. 91: 376-384. PMID 25636761 DOI: 10.1016/J.Ijrobp.2014.10.012 |
0.398 |
|
| 2015 |
van Gijn W, van Stiphout RG, van de Velde CJ, Valentini V, Lammering G, Gambacorta MA, Påhlman L, Bujko K, Lambin P. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 26: 928-35. PMID 25609247 DOI: 10.1093/Annonc/Mdv023 |
0.328 |
|
| 2015 |
Zegers CM, Rekers NH, Quaden DH, Lieuwes NG, Yaromina A, Germeraad WT, Wieten L, Biessen EA, Boon L, Neri D, Troost EG, Dubois LJ, Lambin P. Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1151-60. PMID 25552483 DOI: 10.1158/1078-0432.Ccr-14-2676 |
0.305 |
|
| 2015 |
Van De Voorde L, Vanneste B, Houben R, Damen P, van den Bogaard J, Lammering G, Dejong K, de Vos-Geelen J, Buijsen J, Öllers M, Berbée M, Lambin P. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 41: 249-56. PMID 25468743 DOI: 10.1016/J.Ejso.2014.10.053 |
0.364 |
|
| 2015 |
Yao CQ, Nguyen F, Haider S, Starmans MHW, Lambin P, Boutros PC. The transcriptomic profile of ovarian cancer grading. Cancer Medicine. 4: 56-64. PMID 25314936 DOI: 10.1002/Cam4.343 |
0.303 |
|
| 2015 |
Parmar C, Leijenaar RTH, Grossmann P, Velazquez ER, Bussink J, Rietveld D, Rietbergen MM, Haibe-Kains B, Lambin P, Aerts HJWL. Radiomic feature clusters and Prognostic Signatures specific for Lung and Head &neck cancer Scientific Reports. 5. DOI: 10.1038/Srep11044 |
0.313 |
|
| 2015 |
Oberije C, Deasy J, Lievens Y, Belderbos J, Vandecasteele K, Uyterlinde W, Rimner A, Troost E, Lambin P. PO-0669: External validation of a survival model for stage III NSCLC: focus on similarities or differences? Radiotherapy and Oncology. 115: S326-S327. DOI: 10.1016/S0167-8140(15)40661-9 |
0.384 |
|
| 2014 |
Stiphout RGPMv, Valentini V, Buijsen J, Lammering G, Meldolesi E, Soest Jv, Leccisotti L, Giordano A, Gambacorta MA, Dekker A, Lambin P. Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: A multicentric prospective study with external validation Radiotherapy and Oncology. 113: 215-222. PMID 25466368 DOI: 10.1016/J.Radonc.2014.11.002 |
0.343 |
|
| 2014 |
Pettersen EO, Ebbesen P, Gieling RG, Williams KJ, Dubois L, Lambin P, Ward C, Meehan J, Kunkler IH, Langdon SP, Ree AH, Flatmark K, Lyng H, Calzada MJ, Peso LD, et al. Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium. Journal of Enzyme Inhibition and Medicinal Chemistry. 1-33. PMID 25347767 DOI: 10.3109/14756366.2014.966704 |
0.322 |
|
| 2014 |
Zegers CM, van Elmpt W, Reymen B, Even AJ, Troost EG, Ollers MC, Hoebers FJ, Houben RM, Eriksson J, Windhorst AD, Mottaghy FM, De Ruysscher D, Lambin P. In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6389-97. PMID 25316821 DOI: 10.1158/1078-0432.Ccr-14-1524 |
0.316 |
|
| 2014 |
Dekker A, Vinod S, Holloway L, Oberije C, George A, Goozee G, Delaney GP, Lambin P, Thwaites D. Rapid learning in practice: a lung cancer survival decision support system in routine patient care data. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 113: 47-53. PMID 25241994 DOI: 10.1016/J.Radonc.2014.08.013 |
0.372 |
|
| 2014 |
Rekers NH, Troost EG, Zegers CM, Germeraad WT, Dubois LJ, Lambin P. Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 18: 391-5. PMID 25179250 DOI: 10.1016/J.Canrad.2014.06.012 |
0.341 |
|
| 2014 |
Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Cavalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, ... ... Lambin P, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nature Communications. 5: 4006. PMID 24892406 DOI: 10.1038/Ncomms5006 |
0.349 |
|
| 2014 |
Smits KM, Melotte V, Niessen HE, Dubois L, Oberije C, Troost EG, Starmans MH, Boutros PC, Vooijs M, van Engeland M, Lambin P. Epigenetics in radiotherapy: where are we heading? Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 111: 168-77. PMID 24861629 DOI: 10.1016/J.Radonc.2014.05.001 |
0.332 |
|
| 2014 |
Oberije C, Nalbantov G, Dekker Ad, Boersma L, Borger J, Reymen B, Baardwijk Av, Wanders R, Ruysscher Dd, Steyerberg E, Dingemans A, Lambin P. A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making Radiotherapy and Oncology. 112: 37-43. PMID 24846083 DOI: 10.1016/J.Radonc.2014.04.012 |
0.341 |
|
| 2014 |
Buijsen J, Stiphout RGv, Menheere PPCA, Lammering G, Lambin P. Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer. Radiotherapy and Oncology. 111: 237-242. PMID 24746569 DOI: 10.1016/J.Radonc.2014.03.006 |
0.327 |
|
| 2014 |
Dingemans AM, Bootsma G, van Baardwijk A, Reymen B, Wanders R, Brans B, Das M, Hochstenbag M, van Belle A, Houben R, Lambin P, de Ruysscher D. A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 710-6. PMID 24722157 DOI: 10.1097/Jto.0000000000000151 |
0.344 |
|
| 2014 |
Hoeben BA, Starmans MH, Leijenaar RT, Dubois LJ, van der Kogel AJ, Kaanders JH, Boutros PC, Lambin P, Bussink J. Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors. Bmc Cancer. 14: 130. PMID 24571588 DOI: 10.1186/1471-2407-14-130 |
0.314 |
|
| 2014 |
Reymen B, Baardwijk Av, Wanders R, Borger J, Dingemans AC, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, Ruysscher DD. Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR) Radiotherapy and Oncology. 110: 482-487. PMID 24444527 DOI: 10.1016/J.Radonc.2013.12.005 |
0.326 |
|
| 2014 |
Schlijper RCJ, Grutters JPC, Houben R, Dingemans AC, Wildberger JE, Raemdonck DV, Cutsem EV, Haustermans K, Lammering G, Lambin P, Ruysscher DD. What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation? Cancer Treatment Reviews. 40: 60-67. PMID 23768754 DOI: 10.1016/J.Ctrv.2013.05.004 |
0.304 |
|
| 2014 |
Rancati T, Talbot C, Azria D, Brookes A, Burr T, Chang-Claude J, Davidson S, Ruysscher DD, Dunning A, Elliot RM, Gutierrez-Enríquez S, Lambin P, Rosenstein B, Symonds RP, Thierens H, et al. The REQUITE project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side effects. Journal of Clinical Oncology. 32: 276-276. DOI: 10.1200/Jco.2014.32.4_Suppl.276 |
0.306 |
|
| 2013 |
Liew MS, Sia J, Starmans MH, Tafreshi A, Harris S, Feigen M, White S, Zimet A, Lambin P, Boutros PC, Mitchell P, John T. Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer. Cancer Medicine. 2: 916-24. PMID 24403265 DOI: 10.1002/Cam4.142 |
0.327 |
|
| 2013 |
Velazquez ER, Parmar C, Jermoumi M, Mak RH, van Baardwijk A, Fennessy FM, Lewis JH, De Ruysscher D, Kikinis R, Lambin P, Aerts HJ. Volumetric CT-based segmentation of NSCLC using 3D-Slicer. Scientific Reports. 3: 3529. PMID 24346241 DOI: 10.1038/Srep03529 |
0.302 |
|
| 2013 |
Carvalho S, Leijenaar RT, Velazquez ER, Oberije C, Parmar C, van Elmpt W, Reymen B, Troost EG, Oellers M, Dekker A, Gillies R, Aerts HJ, Lambin P. Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer. Acta Oncologica (Stockholm, Sweden). 52: 1398-404. PMID 24047338 DOI: 10.3109/0284186X.2013.812795 |
0.37 |
|
| 2013 |
Leijenaar RT, Carvalho S, Velazquez ER, van Elmpt WJ, Parmar C, Hoekstra OS, Hoekstra CJ, Boellaard R, Dekker AL, Gillies RJ, Aerts HJ, Lambin P. Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncologica (Stockholm, Sweden). 52: 1391-7. PMID 24047337 DOI: 10.3109/0284186X.2013.812798 |
0.334 |
|
| 2013 |
van Elmpt W, Das M, Hüllner M, Sharifi H, Zegers CM, Reymen B, Lambin P, Wildberger JE, Troost EG, Veit-Haibach P, De Ruysscher D. Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109: 65-70. PMID 24044795 DOI: 10.1016/J.Radonc.2013.08.032 |
0.33 |
|
| 2013 |
Nalbantov G, Kietselaer B, Vandecasteele K, Oberije C, Berbee M, Troost E, Dingemans AM, van Baardwijk A, Smits K, Dekker A, Bussink J, De Ruysscher D, Lievens Y, Lambin P. Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109: 100-6. PMID 24044794 DOI: 10.1016/J.Radonc.2013.08.035 |
0.326 |
|
| 2013 |
Zegers CM, van Elmpt W, Wierts R, Reymen B, Sharifi H, Öllers MC, Hoebers F, Troost EG, Wanders R, van Baardwijk A, Brans B, Eriksson J, Windhorst B, Mottaghy FM, De Ruysscher D, ... Lambin P, et al. Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109: 58-64. PMID 24044790 DOI: 10.1016/J.Radonc.2013.08.031 |
0.316 |
|
| 2013 |
Fontanarosa D, van der Laan HP, Witte M, Shakirin G, Roelofs E, Langendijk JA, Lambin P, van Herk M. An in silico comparison between margin-based and probabilistic target-planning approaches in head and neck cancer patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109: 430-6. PMID 24044789 DOI: 10.1016/J.Radonc.2013.07.012 |
0.316 |
|
| 2013 |
John T, Starmans MH, Chen YT, Russell PA, Barnett SA, White SC, Mitchell PL, Walkiewicz M, Azad A, Lambin P, Tsao MS, Deb S, Altorki N, Wright G, Knight S, et al. The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer. Plos One. 8: e67876. PMID 23935846 DOI: 10.1371/Journal.Pone.0067876 |
0.322 |
|
| 2013 |
Theys J, Yahyanejad S, Habets R, Span P, Dubois L, Paesmans K, Kattenbeld B, Cleutjens J, Groot AJ, Schuurbiers OC, Lambin P, Bussink J, Vooijs M. High NOTCH activity induces radiation resistance in non small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 108: 440-5. PMID 23891097 DOI: 10.1016/J.Radonc.2013.06.020 |
0.345 |
|
| 2013 |
Langendijk JA, Lambin P, De Ruysscher D, Widder J, Bos M, Verheij M. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 107: 267-73. PMID 23759662 DOI: 10.1016/J.Radonc.2013.05.007 |
0.309 |
|
| 2013 |
Buijsen J, Lammering G, Jansen RL, Beets GL, Wals J, Sosef M, Den Boer MO, Leijtens J, Riedl RG, Theys J, Lambin P. Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 107: 184-8. PMID 23647753 DOI: 10.1016/J.Radonc.2013.03.023 |
0.327 |
|
| 2013 |
Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T, Verheij M, van den Brekel M, Vogel W, Slevin N, Deutsch E, Sonke JJ, Lambin P, Rasch C. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. Bmc Cancer. 13: 84. PMID 23433435 DOI: 10.1186/1471-2407-13-84 |
0.369 |
|
| 2013 |
Ramaekers BLT, Grutters JPC, Pijls-Johannesma M, Lambin P, Joore MA, Langendijk JA. Protons in head-and-neck cancer: bridging the gap of evidence International Journal of Radiation Oncology Biology Physics. 85: 1282-1288. PMID 23273998 DOI: 10.1016/J.Ijrobp.2012.11.006 |
0.311 |
|
| 2013 |
Reymen B, Loon JV, Baardwijk Av, Wanders R, Borger J, Dingemans AC, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, Ruysscher DD. Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 85: 1319-1324. PMID 23200174 DOI: 10.1016/J.Ijrobp.2012.10.003 |
0.392 |
|
| 2013 |
Lambin P, Stiphout RGPMv, Starmans MHW, Rios-Velazquez E, Nalbantov G, Aerts HJWL, Roelofs E, Elmpt Wv, Boutros PC, Granone P, Valentini V, Begg AC, Ruysscher DD, Dekker A. Predicting outcomes in radiation oncology--multifactorial decision support systems Nature Reviews Clinical Oncology. 10: 27-40. PMID 23165123 DOI: 10.1038/Nrclinonc.2012.196 |
0.307 |
|
| 2013 |
Hatt M, van Stiphout R, le Pogam A, Lammering G, Visvikis D, Lambin P. Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET. Acta Oncologica (Stockholm, Sweden). 52: 619-26. PMID 22873767 DOI: 10.3109/0284186X.2012.702923 |
0.329 |
|
| 2013 |
Ruysscher DD, Belderbos J, Reymen B, Elmpt Wv, Baardwijk Av, Wanders R, Hoebers F, Vooijs M, Öllers M, Lambin P. State of the Art Radiation Therapy for Lung Cancer 2012: A Glimpse of the Future Clinical Lung Cancer. 14: 89-95. PMID 22853981 DOI: 10.1016/J.Cllc.2012.06.006 |
0.349 |
|
| 2013 |
Liew MS, Sia J, Harris SJ, Tafreshi A, Starmans MH, Feigen M, Boutros PC, White S, Zimet AS, Lambin P, Mitchell P, John T. Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel (PC) or cisplatin/etoposide (PE) in stage III non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E18559 |
0.325 |
|
| 2013 |
Hatt M, Lambin P, Kinahan P. TU‐A‐141‐01: Multi Modal PET/CT Imaging for Therapy Response Early Prediction and Therapy Monitoring Medical Physics. 40: 425-425. DOI: 10.1118/1.4815346 |
0.316 |
|
| 2012 |
Rios Velazquez E, Aerts HJ, Gu Y, Goldgof DB, De Ruysscher D, Dekker A, Korn R, Gillies RJ, Lambin P. A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 105: 167-73. PMID 23157978 DOI: 10.1016/J.Radonc.2012.09.023 |
0.346 |
|
| 2012 |
Starmans MH, Pintilie M, John T, Der SD, Shepherd FA, Jurisica I, Lambin P, Tsao MS, Boutros PC. Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies. Genome Medicine. 4: 84. PMID 23146350 DOI: 10.1186/Gm385 |
0.307 |
|
| 2012 |
van Baardwijk A, Tomé WA, van Elmpt W, Bentzen SM, Reymen B, Wanders R, Houben R, Ollers M, Lambin P, De Ruysscher D. Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 105: 145-9. PMID 23068707 DOI: 10.1016/J.Radonc.2012.09.008 |
0.341 |
|
| 2012 |
Ruysscher DD, Wanders R, Baardwijk Av, Dingemans AC, Reymen B, Houben R, Bootsma G, Pitz C, Eijsden Lv, Geraedts W, Baumert BG, Lambin P. Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450) Journal of Thoracic Oncology. 7: 1547-1555. PMID 22982655 DOI: 10.1097/Jto.0B013E318262Caf6 |
0.348 |
|
| 2012 |
Elmpt Wv, Öllers M, Dingemans AC, Lambin P, Ruysscher DD. Response Assessment Using 18F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer The Journal of Nuclear Medicine. 53: 1514-1520. PMID 22879081 DOI: 10.2967/Jnumed.111.102566 |
0.367 |
|
| 2012 |
van der Heide UA, Houweling AC, Groenendaal G, Beets-Tan RG, Lambin P. Functional MRI for radiotherapy dose painting. Magnetic Resonance Imaging. 30: 1216-23. PMID 22770686 DOI: 10.1016/J.Mri.2012.04.010 |
0.341 |
|
| 2012 |
Starmans MH, Lieuwes NG, Span PN, Haider S, Dubois L, Nguyen F, van Laarhoven HW, Sweep FC, Wouters BG, Boutros PC, Lambin P. Independent and functional validation of a multi-tumour-type proliferation signature. British Journal of Cancer. 107: 508-15. PMID 22722312 DOI: 10.1038/Bjc.2012.269 |
0.347 |
|
| 2012 |
van Baardwijk A, Reymen B, Wanders S, Borger J, Ollers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Lunde R, Peters F, Lambin P, De Ruysscher D. Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer. European Journal of Cancer (Oxford, England : 1990). 48: 2339-46. PMID 22608261 DOI: 10.1016/J.Ejca.2012.04.014 |
0.345 |
|
| 2012 |
Ruysscher DD, Meerbeeck JV, Vandecasteele K, Oberije C, Pijls M, Dingemans AMC, Reymen B, Baardwijk Av, Wanders R, Lammering G, Lambin P, Neve WD. Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor? Strahlentherapie Und Onkologie. 188: 564-567. PMID 22543884 DOI: 10.1007/S00066-012-0098-Z |
0.336 |
|
| 2012 |
Buijsen J, van den Bogaard J, van der Weide H, Engelsman S, van Stiphout R, Janssen M, Beets G, Beets-Tan R, Lambin P, Lammering G. FDG-PET-CT reduces the interobserver variability in rectal tumor delineation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 102: 371-6. PMID 22280807 DOI: 10.1016/J.Radonc.2011.12.016 |
0.324 |
|
| 2012 |
Ruysscher DD, Baardwijk Av, Steevens J, Botterweck A, Bosmans G, Reymen B, Wanders R, Borger J, Dingemans AC, Bootsma G, Pitz C, Lunde R, Geraedts W, Oellers M, Dekker A, ... Lambin P, et al. Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study Radiotherapy and Oncology. 102: 228-233. PMID 22100659 DOI: 10.1016/J.Radonc.2011.10.010 |
0.361 |
|
| 2012 |
Roelofs E, Engelsman M, Rasch C, Persoon L, Qamhiyeh S, Ruysscher Dd, Verhaegen F, Pijls-Johannesma M, Lambin P. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer. Journal of Thoracic Oncology. 7: 165-176. PMID 22071782 DOI: 10.1097/Jto.0B013E31823529Fc |
0.358 |
|
| 2012 |
Aerts HJWL, Bussink J, Oyen WJG, Elmpt Wv, Folgering AM, Emans D, Velders M, Lambin P, Ruysscher DD. Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. Lung Cancer. 75: 73-76. PMID 21782272 DOI: 10.1016/J.Lungcan.2011.06.003 |
0.329 |
|
| 2012 |
Janssen MH, Aerts HJ, Buijsen J, Lambin P, Lammering G, Öllers MC. Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusion. International Journal of Radiation Oncology, Biology, Physics. 82: 849-55. PMID 21392896 DOI: 10.1016/J.Ijrobp.2010.10.029 |
0.316 |
|
| 2012 |
Janssen MH, Öllers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, Lambin P, Lammering G. PET-based treatment response evaluation in rectal cancer: prediction and validation. International Journal of Radiation Oncology, Biology, Physics. 82: 871-6. PMID 21377810 DOI: 10.1016/J.Ijrobp.2010.11.038 |
0.357 |
|
| 2012 |
Elmpt Wv, Öllers M, Lambin P, Ruysscher DD. Should patient setup in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated positron emission tomography/computed tomography imaging. International Journal of Radiation Oncology Biology Physics. 82: 379-385. PMID 21093173 DOI: 10.1016/J.Ijrobp.2010.09.016 |
0.373 |
|
| 2012 |
Ruysscher DD, Wanders R, Baardwijk Av, Dingemans AC, Reymen B, Bootsma G, Pitz C, Geraedts W, Baumert B, Lambin P. Radical Treatment Of Non-Small Cell Lung Cancer Patients With Synchronous Oligometastases: Long-Term Results Of A Prospective Phase Ii Trial (Nct01282450) Annals of Oncology. 23: 425-425. DOI: 10.1016/S0923-7534(20)33894-1 |
0.344 |
|
| 2012 |
Sharifi H, Elmpt Wv, Vandendries R, Dingemans AC, Das M, Nalbantov G, Oellers M, Lambin P, Belderbos J, Ruysscher DD. Ct Based Quantification Of Radiation Induced Lung Damage (Rild) And The Interaction With Chemotherapy And Cetuximab Annals of Oncology. 23: 396-397. DOI: 10.1016/S0923-7534(20)33770-4 |
0.384 |
|
| 2012 |
Ruysscher DD, Elmpt Wv, Wanders R, Baardwijk Av, Dingemans AC, Reymen B, Bootsma G, Lambin P, Sonke J, Belderbos J. Acute Toxicity of Full-Dose Cisplatin-Etoposide Concurrently with High-Dose Hypofractionated Chest Radiotherapy for Stage III Non-Small Cell Lung Cancer: Subset Analysis of Non-Randomised Patients in the Pet-Boost Phase II Trial (NCT01024829) Annals of Oncology. 23: 396-396. DOI: 10.1016/S0923-7534(20)33767-4 |
0.336 |
|
| 2012 |
Elmpt Wv, Ollers M, Dingemans AC, Lambin P, Ruysscher DD. 18F-FDG-PET Response During the Second Week of Concurrent or Sequential Chemo-Radiotherapy Significantly Correlates with 2-Year Survival in NSCLC Patients Annals of Oncology. 23: 392-392. DOI: 10.1016/S0923-7534(20)33754-6 |
0.348 |
|
| 2011 |
Ruysscher DD, Elmpt Wv, Lambin P. Radiotherapy with curative intent for lung cancer: A continuing success story Radiotherapy and Oncology. 101: 237-239. PMID 22079528 DOI: 10.1016/J.Radonc.2011.10.019 |
0.376 |
|
| 2011 |
Egelmeer AG, Velazquez ER, de Jong JM, Oberije C, Geussens Y, Nuyts S, Kremer B, Rietveld D, Leemans CR, de Jong MC, Rasch C, Hoebers F, Homer J, Slevin N, West C, ... Lambin P, et al. Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 100: 108-15. PMID 21784544 DOI: 10.1016/J.Radonc.2011.06.023 |
0.33 |
|
| 2011 |
Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rödel C, Sainato A, Sauer R, Minsky BD, ... ... Lambin P, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3163-72. PMID 21747092 DOI: 10.1200/Jco.2010.33.1595 |
0.332 |
|
| 2011 |
Wanders R, Steevens J, Botterweck A, Dingemans AC, Reymen B, Baardwijk Av, Borger J, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, Ruysscher DD. Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study. European Journal of Cancer. 47: 2691-2697. PMID 21733675 DOI: 10.1016/J.Ejca.2011.06.023 |
0.334 |
|
| 2011 |
Dubois L, Peeters S, Lieuwes NG, Geusens N, Thiry A, Wigfield S, Carta F, McIntyre A, Scozzafava A, Dogné JM, Supuran CT, Harris AL, Masereel B, Lambin P. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 99: 424-31. PMID 21676479 DOI: 10.1016/J.Radonc.2011.05.045 |
0.304 |
|
| 2011 |
van den Bogaard J, Janssen MH, Janssens G, Buijsen J, Reniers B, Lambin P, Lammering G, Ollers MC. Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 99: 137-41. PMID 21571386 DOI: 10.1016/J.Radonc.2011.04.004 |
0.336 |
|
| 2011 |
Loon Jv, Offermann C, Öllers M, Elmpt Wv, Vegt E, Rahmy A, Dingemans AC, Lambin P, Ruysscher DD. Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study. Radiotherapy and Oncology. 99: 172-175. PMID 21571382 DOI: 10.1016/J.Radonc.2011.03.014 |
0.358 |
|
| 2011 |
Loon Jv, Baardwijk Av, Boersma L, Öllers M, Lambin P, Ruysscher DD. Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer. Cancer Treatment Reviews. 37: 331-343. PMID 21320756 DOI: 10.1016/J.Ctrv.2011.01.005 |
0.36 |
|
| 2011 |
Buijsen J, van den Bogaard J, Janssen MH, Bakers FC, Engelsman S, Öllers M, Beets-Tan RG, Nap M, Beets GL, Lambin P, Lammering G. FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 98: 270-6. PMID 21295874 DOI: 10.1016/J.Radonc.2010.11.018 |
0.338 |
|
| 2011 |
van Elmpt W, Hamill J, Jones J, De Ruysscher D, Lambin P, Ollers M. Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours. European Journal of Nuclear Medicine and Molecular Imaging. 38: 843-55. PMID 21222120 DOI: 10.1007/S00259-010-1716-6 |
0.302 |
|
| 2011 |
van Stiphout RG, Lammering G, Buijsen J, Janssen MH, Gambacorta MA, Slagmolen P, Lambrecht M, Rubello D, Gava M, Giordano A, Postma EO, Haustermans K, Capirci C, Valentini V, Lambin P. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 98: 126-33. PMID 21176986 DOI: 10.1016/J.Radonc.2010.12.002 |
0.325 |
|
| 2011 |
Dehing-Oberije C, Aerts H, Yu S, De Ruysscher D, Menheere P, Hilvo M, van der Weide H, Rao B, Lambin P. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325). International Journal of Radiation Oncology, Biology, Physics. 81: 360-8. PMID 20888135 DOI: 10.1016/J.Ijrobp.2010.06.011 |
0.351 |
|
| 2011 |
Ramaekers BLT, Pijls-Johannesma M, Joore MA, Ende Pvd, Langendijk JA, Lambin P, Kessels AGH, Grutters JPC. Systematic review and meta-analysis of radiotherapy in various head and neck cancers: Comparing photons, carbon-ions and protons Cancer Treatment Reviews. 37: 185-201. PMID 20817407 DOI: 10.1016/J.Ctrv.2010.08.004 |
0.315 |
|
| 2011 |
Elmpt Wv, Öllers M, Herwijnen Hv, Holder Ld, Vercoulen L, Wouters M, Lambin P, Ruysscher DD. Volume or Position Changes of Primary Lung Tumor During (Chemo-)Radiotherapy Cannot Be Used as a Surrogate for Mediastinal Lymph Node Changes: The Case for Optimal Mediastinal Lymph Node Imaging During Radiotherapy International Journal of Radiation Oncology Biology Physics. 79: 89-95. PMID 20421149 DOI: 10.1016/J.Ijrobp.2009.10.059 |
0.33 |
|
| 2011 |
Baardwijk Av, Reymen B, Wanders R, Dingemans AC, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, Ruysscher DD. Mature Results of a Phase II Trial on Individualized Radiation Dose-escalation Based on Normal Tissue Constraints in Concurrent Chemo-radiation for Stage III Non-small Cell Lung Cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.275 |
0.335 |
|
| 2010 |
Dehing-Oberije C, De Ruysscher D, Petit S, Van Meerbeeck J, Vandecasteele K, De Neve W, Dingemans AM, El Naqa I, Deasy J, Bradley J, Huang E, Lambin P. Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 97: 455-61. PMID 21084125 DOI: 10.1016/J.Radonc.2010.09.028 |
0.524 |
|
| 2010 |
Petit SF, Elmpt WJCv, Oberije CJG, Vegt E, Dingemans AC, Lambin P, Dekker ALAJ, Ruysscher DD. [18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients International Journal of Radiation Oncology Biology Physics. 81: 698-705. PMID 20884128 DOI: 10.1016/J.Ijrobp.2010.06.016 |
0.347 |
|
| 2010 |
Grutters JPC, Joore MA, Wiegman EM, Langendijk JA, Ruysscher Dd, Hochstenbag M, Botterweck A, Lambin P, Pijls-Johannesma M. Health-related quality of life in patients surviving non-small cell lung cancer Thorax. 65: 903-907. PMID 20861294 DOI: 10.1136/Thx.2010.136390 |
0.308 |
|
| 2010 |
Jimenez MF, van Baardwijk A, Aerts HJ, De Ruysscher D, Novoa NM, Varela G, Lambin P. Effectiveness of surgery and individualized high-dose hyperfractionated accelerated radiotherapy on survival in clinical stage I non-small cell lung cancer. A propensity score matched analysis. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 97: 413-7. PMID 20851487 DOI: 10.1016/J.Radonc.2010.08.016 |
0.352 |
|
| 2010 |
Velazquez ER, Aerts HJWL, Oberije C, Ruysscher DD, Lambin P. Prediction of residual metabolic activity after treatment in NSCLC patients Acta Oncologica. 49: 1033-1039. PMID 20831492 DOI: 10.3109/0284186X.2010.498441 |
0.358 |
|
| 2010 |
Lammering G, Ruysscher DD, Baardwijk Av, Baumert BG, Borger J, Lutgens L, Ende Pvd, Öllers M, Lambin P. The Use of FDG-PET to Target Tumors by Radiotherapy Strahlentherapie Und Onkologie. 186: 471-481. PMID 20814658 DOI: 10.1007/S00066-010-2150-1 |
0.36 |
|
| 2010 |
Lambin P, Petit SF, Aerts HJWL, Elmpt WJCv, Oberije CJG, Starmans MHW, Stiphout RGPMv, Dongen GAMSv, Muylle K, Flamen P, Dekker ALAJ, Ruysscher DD. The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer Radiotherapy and Oncology. 96: 145-152. PMID 20647155 DOI: 10.1016/J.Radonc.2010.07.001 |
0.356 |
|
| 2010 |
Aerts HJWL, Lambin P, Ruysscher DD. FDG for dose painting: a rational choice. Radiotherapy and Oncology. 97: 163-164. PMID 20561697 DOI: 10.1016/J.Radonc.2010.05.001 |
0.365 |
|
| 2010 |
Jayasurya K, Fung G, Yu S, Dehing-Oberije C, Ruysscher DD, Hope A, Neve WD, Lievens Y, Lambin P, Dekker ALAJ. Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy. Medical Physics. 37: 1401-1407. PMID 20443461 DOI: 10.1118/1.3352709 |
0.326 |
|
| 2010 |
van Loon J, Janssen MH, Ollers M, Aerts HJ, Dubois L, Hochstenbag M, Dingemans AM, Lalisang R, Brans B, Windhorst B, van Dongen GA, Kolb H, Zhang J, De Ruysscher D, Lambin P. PET imaging of hypoxia using [18F]HX4: a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging. 37: 1663-8. PMID 20369236 DOI: 10.1007/S00259-010-1437-X |
0.319 |
|
| 2010 |
Grutters JPC, Pijls-Johannesma M, Ruysscher DD, Peeters A, Reimoser S, Severens JL, Lambin P, Joore MA. The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research. Cancer Treatment Reviews. 36: 468-476. PMID 20303217 DOI: 10.1016/J.Ctrv.2010.02.018 |
0.307 |
|
| 2010 |
Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA, Lammering G, De Ruysscher DK, Lambin P. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. The Cochrane Database of Systematic Reviews. CD006377. PMID 20238344 DOI: 10.1002/14651858.Cd006377.Pub3 |
0.355 |
|
| 2010 |
Janssen MH, Ollers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, Lambin P, Lammering G. Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 95: 203-8. PMID 20176406 DOI: 10.1016/J.Radonc.2010.01.021 |
0.336 |
|
| 2010 |
Baardwijk Av, Wanders S, Boersma L, Borger J, Öllers M, Dingemans AC, Bootsma G, Geraedts W, Pitz C, Lunde R, Lambin P, Ruysscher DD. Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer Journal of Clinical Oncology. 28: 1380-1386. PMID 20142596 DOI: 10.1200/Jco.2009.24.7221 |
0.353 |
|
| 2010 |
Hatt M, Rest CCl, Descourt P, Dekker A, Ruysscher DD, Oellers M, Lambin P, Pradier O, Visvikis D. Accurate Automatic Delineation Of Heterogeneous Functional Volumes In Positron Emission Tomography For Oncology Applications International Journal of Radiation Oncology Biology Physics. 77: 301-308. PMID 20116934 DOI: 10.1016/J.Ijrobp.2009.08.018 |
0.317 |
|
| 2010 |
Janssen MH, Ollers MC, van Stiphout RG, Buijsen J, van den Bogaard J, de Ruysscher D, Lambin P, Lammering G. Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 94: 151-5. PMID 20116114 DOI: 10.1016/J.Radonc.2009.12.033 |
0.371 |
|
| 2010 |
Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA, Lammering G, De Ruysscher DK, Lambin P. Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. The Cochrane Database of Systematic Reviews. CD006377. PMID 20091593 DOI: 10.1002/14651858.Cd006377.Pub2 |
0.329 |
|
| 2010 |
Elmpt Wv, Petit S, Ruysscher DD, Lambin P, Dekker A. 3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer. Radiotherapy and Oncology. 94: 188-194. PMID 20083317 DOI: 10.1016/J.Radonc.2009.12.024 |
0.349 |
|
| 2010 |
Janssen MHM, Aerts HJWL, Kierkels RGJ, Backes WH, Öllers MC, Buijsen J, Lambin P, Lammering G. Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: Sequential perfusion-CT findings Radiotherapy and Oncology. 94: 156-160. PMID 20080311 DOI: 10.1016/J.Radonc.2009.12.013 |
0.313 |
|
| 2010 |
Petit SF, Elmpt WJCv, Lambin P, Dekker ALAJ. Dose recalculation in megavoltage cone-beam CT for treatment evaluation: Removal of cupping and truncation artefacts in scans of the thorax and abdomen Radiotherapy and Oncology. 94: 359-366. PMID 20060186 DOI: 10.1016/J.Radonc.2009.12.001 |
0.318 |
|
| 2010 |
Jager JJ, Keymeulen K, Beets-Tan RGH, Hupperets P, Kroonenburgh Mv, Houben R, Ruysscher Dd, Lambin P, Boersma LJ. FDG-PET-CT for staging of high-risk breast cancer patients reduces the number of further examinations: A pilot study. Acta Oncologica. 49: 185-191. PMID 20017664 DOI: 10.3109/02841860903440262 |
0.316 |
|
| 2010 |
Loon Jv, Grutters JPC, Wanders R, Boersma L, Dingemans AC, Bootsma G, Geraedts W, Pitz C, Simons JP, Brans B, Snoep G, Hochstenbag M, Lambin P, Ruysscher DD. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation. European Journal of Cancer. 46: 110-119. PMID 19944595 DOI: 10.1016/J.Ejca.2009.10.028 |
0.328 |
|
| 2010 |
Loon Jv, Ruysscher DD, Wanders R, Boersma L, Simons JP, Oellers M, Dingemans AC, Hochstenbag M, Bootsma G, Geraedts W, Pitz C, Teule J, Rhami A, Thimister W, Snoep G, ... ... Lambin P, et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. International Journal of Radiation Oncology Biology Physics. 77: 329-336. PMID 19782478 DOI: 10.1016/J.Ijrobp.2009.04.075 |
0.358 |
|
| 2010 |
Kierkels RGJ, Backes WH, Janssen MHM, Buijsen J, Beets-Tan RGH, Lambin P, Lammering G, Oellers MC, Aerts HJWL. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer. International Journal of Radiation Oncology Biology Physics. 77: 400-408. PMID 19733445 DOI: 10.1016/J.Ijrobp.2009.05.015 |
0.301 |
|
| 2010 |
Grutters JPC, Kessels AGH, Pijls-Johannesma M, Ruysscher DD, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis Radiotherapy and Oncology. 95: 32-40. PMID 19733410 DOI: 10.1016/J.Radonc.2009.08.003 |
0.318 |
|
| 2010 |
Janssen MH, Ollers MC, Riedl RG, van den Bogaard J, Buijsen J, van Stiphout RG, Aerts HJ, Lambin P, Lammering G. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. International Journal of Radiation Oncology, Biology, Physics. 77: 392-9. PMID 19646825 DOI: 10.1016/J.Ijrobp.2009.04.030 |
0.356 |
|
| 2010 |
Baardwijk AV, Wanders R, Reymen B, Borger J, Dingemans A, Bootsma G, Pitz C, Geraedts W, Lambin P, Ruysscher DD. First Results of a Phase II Trial Investigating Individualized Dose-escalation Based on Normal Tissue Constraints in Concurrent Chemo-radiation for Locally Advanced Non-small Cell Lung Cancer (NSCLC) (NCT00572325) International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.278 |
0.343 |
|
| 2010 |
Elmpt Wv, Öllers M, Lambin P, Ruysscher DD. Repeated PET/CT Imaging in NSCLC: The Impact of Volumetric Changes and Baseline Shifts of the Tumor on the Radiotherapy Plan Quality International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.1241 |
0.32 |
|
| 2009 |
Rosario T, Öllers MC, Bosmans G, Ruysscher DD, Lambin P, Dekker A. Phased Versus Midventilation Attenuation-Corrected Respiration-Correlated PET for Patients with Non–Small Cell Lung Cancer Journal of Nuclear Medicine Technology. 37: 208-214. PMID 19914979 DOI: 10.2967/Jnmt.109.066845 |
0.35 |
|
| 2009 |
Janssens G, Orban De Xivry J, Fekkes S, Dekker A, MacQ B, Lambin P, Van Elmpt W. Evaluation of nonrigid registration models for interfraction dose accumulation in radiotherapy Medical Physics. 36: 4268-4276. PMID 19810501 DOI: 10.1118/1.3194750 |
0.324 |
|
| 2009 |
De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, van Mastrigt GA, De Ruysscher DK, Lambin P, van der Zee J. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. The Cochrane Database of Systematic Reviews. CD006269. PMID 19588384 DOI: 10.1002/14651858.Cd006269.Pub2 |
0.347 |
|
| 2009 |
Lambin P, Ramaekers BLT, Mastrigt GAPGv, Ende PVd, Jong Jd, Ruysscher DKMD, Pijls-Johannesma M. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Database of Systematic Reviews. 2009: 6158. PMID 19588382 DOI: 10.1002/14651858.Cd006158.Pub2 |
0.341 |
|
| 2009 |
De Ruysscher D, Dehing C, Bentzen SM, Houben R, Dekker A, Wanders R, Borger J, Hochstenbag M, Boersma L, Geskes G, Dingemans AM, Bootsma G, Lammering G, Lambin P. Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 93: 389-95. PMID 19576645 DOI: 10.1016/J.Radonc.2009.06.004 |
0.35 |
|
| 2009 |
Aerts HJWL, Baardwijk AAWv, Petit SF, Offermann C, Loon Jv, Houben R, Dingemans AC, Wanders R, Boersma L, Borger J, Bootsma G, Geraedts W, Pitz C, Simons J, Wouters BG, ... ... Lambin P, et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan Radiotherapy and Oncology. 91: 386-392. PMID 19329207 DOI: 10.1016/J.Radonc.2009.03.006 |
0.342 |
|
| 2009 |
Petit SF, Aerts HJWL, Loon JGMv, Offermann C, Houben R, Winkens B, Öllers MC, Lambin P, Ruysscher DD, Dekker ALAJ. Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study. Radiotherapy and Oncology. 91: 393-398. PMID 19328570 DOI: 10.1016/J.Radonc.2009.02.020 |
0.364 |
|
| 2009 |
Elmpt Wv, Nijsten S, Petit S, Mijnheer B, Lambin P, Dekker A. 3D In Vivo Dosimetry Using Megavoltage Cone-Beam CT and EPID Dosimetry International Journal of Radiation Oncology Biology Physics. 73: 1580-1587. PMID 19306755 DOI: 10.1016/J.Ijrobp.2008.11.051 |
0.33 |
|
| 2009 |
Pijls-Johannesma M, Houben R, Boersma L, Grutters JPC, Seghers K, Lambin P, Wanders R, Ruysscher DD. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Radiotherapy and Oncology. 91: 443-448. PMID 19297049 DOI: 10.1016/J.Radonc.2009.02.010 |
0.344 |
|
| 2009 |
Ruysscher DD, Houben A, Aerts HJWL, Dehing C, Wanders R, Öllers M, Dingemans AC, Hochstenbag M, Boersma L, Borger J, Dekker A, Lambin P. Increased 18F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): A prospective pilot study Radiotherapy and Oncology. 91: 415-420. PMID 19195730 DOI: 10.1016/J.Radonc.2009.01.004 |
0.357 |
|
| 2009 |
Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 91: 421-6. PMID 19147245 DOI: 10.1016/J.Radonc.2008.12.002 |
0.345 |
|
| 2009 |
Dehing-Oberije C, Yu S, De Ruysscher D, Meersschout S, Van Beek K, Lievens Y, Van Meerbeeck J, De Neve W, Rao B, van der Weide H, Lambin P. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 74: 355-62. PMID 19095367 DOI: 10.1016/J.Ijrobp.2008.08.052 |
0.358 |
|
| 2009 |
Loon Jv, Grutters JPC, Wanders R, Boersma L, Oellers M, Dingemans A, Bootsma G, Geraedts W, Pitz C, Simons J, Fatah SA, Snoep G, Hochstenbag M, Lambin P, Ruysscher DD. Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study. European Journal of Cancer. 45: 588-595. PMID 19046631 DOI: 10.1016/J.Ejca.2008.10.017 |
0.358 |
|
| 2009 |
De Ruysscher D, Dehing C, Yu S, Wanders R, Ollers M, Dingemans AM, Bootsma G, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Borger J, Dekker A, Lambin P. Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 91: 353-9. PMID 19012981 DOI: 10.1016/J.Radonc.2008.10.006 |
0.372 |
|
| 2009 |
Janssen MHM, Aerts HJWL, Öllers MC, Bosmans G, Lee JA, Buijsen J, Ruysscher DD, Lambin P, Lammering G, Dekker ALAJ. Tumor delineation based on time-activity curve differences assessed with dynamic fluorodeoxyglucose positron emission tomography-computed tomography in rectal cancer patients. International Journal of Radiation Oncology Biology Physics. 73: 456-465. PMID 18556143 DOI: 10.1016/J.Ijrobp.2008.04.019 |
0.314 |
|
| 2009 |
Lammering G, Janssen MHM, Öllers MC, Riedl RG, den JBv, van RGPMS, Buijsen J, Aerts HJWL, Lambin P. 6023 The value of PET-CT during radiochemotherapy in the tumour response prediction for rectal cancer Ejc Supplements. 7: 328-328. DOI: 10.1016/S1359-6349(09)71118-8 |
0.312 |
|
| 2008 |
Aerts H, Dubois L, Perk L, Vermaelen P, Dongen Gv, Wouters B, Lambin P. Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET The Journal of Nuclear Medicine. 50: 123-131. PMID 19091906 DOI: 10.2967/Jnumed.108.054312 |
0.314 |
|
| 2008 |
Starmans MH, Krishnapuram B, Steck H, Horlings H, Nuyten DS, van de Vijver MJ, Seigneuric R, Buffa FM, Harris AL, Wouters BG, Lambin P. Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types. British Journal of Cancer. 99: 1884-90. PMID 18985037 DOI: 10.1038/Sj.Bjc.6604746 |
0.332 |
|
| 2008 |
Elmpt Wv, McDermott L, Nijsten S, Wendling M, Lambin P, Mijnheer B. A literature review of electronic portal imaging for radiotherapy dosimetry. Radiotherapy and Oncology. 88: 289-309. PMID 18706727 DOI: 10.1016/J.Radonc.2008.07.008 |
0.329 |
|
| 2008 |
Elmpt Wv, Öllers M, Velders M, Poels K, Mijnheer B, Ruysscher DD, Dekker A, Lambin P, Boersma L. Transition from a simple to a more advanced dose calculation algorithm for radiotherapy of non-small cell lung cancer (NSCLC): Implications for clinical implementation in an individualized dose-escalation protocol Radiotherapy and Oncology. 88: 326-334. PMID 18701177 DOI: 10.1016/J.Radonc.2008.07.003 |
0.314 |
|
| 2008 |
Petit SF, Elmpt WJCv, Nijsten SMJJG, Lambin P, Dekker ALAJ. Calibration of megavoltage cone-beam CT for radiotherapy dose calculations: Correction of cupping artifacts and conversion of CT numbers to electron density Medical Physics. 35: 849-865. PMID 18404922 DOI: 10.1118/1.2836945 |
0.313 |
|
| 2008 |
Loon Jv, Offermann C, Bosmans G, Wanders R, Dekker A, Borger J, Oellers M, Dingemans A, Baardwijk Av, Teule J, Snoep G, Hochstenbag M, Houben R, Lambin P, Ruysscher DD. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiotherapy and Oncology. 87: 49-54. PMID 18342967 DOI: 10.1016/J.Radonc.2008.02.019 |
0.366 |
|
| 2008 |
Baardwijk Av, Bosmans G, Suylen RJv, Kroonenburgh Mv, Hochstenbag M, Geskes G, Lambin P, Ruysscher DD. Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study. Radiotherapy and Oncology. 87: 55-58. PMID 18328584 DOI: 10.1016/J.Radonc.2008.02.002 |
0.317 |
|
| 2008 |
van Baardwijk A, Bosmans G, Bentzen SM, Boersma L, Dekker A, Wanders R, Wouters BG, Lambin P, De Ruysscher D. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial. International Journal of Radiation Oncology, Biology, Physics. 71: 1103-10. PMID 18258382 DOI: 10.1016/J.Ijrobp.2007.11.028 |
0.371 |
|
| 2008 |
Baardwijk Av, Bosmans G, Boersma L, Wanders S, Dekker A, Dingemans AMC, Bootsma G, Geraedts W, Pitz C, Simons J, Lambin P, Ruysscher DD. Individualized Radical Radiotherapy of Non–Small-Cell Lung Cancer Based on Normal Tissue Dose Constraints: A Feasibility Study International Journal of Radiation Oncology Biology Physics. 71: 1394-1401. PMID 18258380 DOI: 10.1016/J.Ijrobp.2007.11.070 |
0.375 |
|
| 2008 |
Aerts HJWL, Bosmans G, Baardwijk AAWv, Dekker ALAJ, Oellers MC, Lambin P, Ruysscher DD. Stability of 18F-Deoxyglucose Uptake Locations Within Tumor During Radiotherapy for NSCLC: A Prospective Study International Journal of Radiation Oncology Biology Physics. 71: 1402-1407. PMID 18234432 DOI: 10.1016/J.Ijrobp.2007.11.049 |
0.312 |
|
| 2008 |
Pijls-Johannesma M, Grutters JPC, Lambin P, Ruysscher DD. Particle therapy in lung cancer: Where do we stand? Cancer Treatment Reviews. 34: 259-267. PMID 18226466 DOI: 10.1016/J.Ctrv.2007.12.003 |
0.335 |
|
| 2008 |
Elmpt Wv, Nijsten S, Mijnheer B, Dekker A, Lambin P. The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations. Radiotherapy and Oncology. 86: 86-92. PMID 18054102 DOI: 10.1016/J.Radonc.2007.11.007 |
0.335 |
|
| 2008 |
Ruysscher DD, Wanders R, Haren Ev, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Verschueren T, Minken A, Bentzen SM, Lambin P. HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. International Journal of Radiation Oncology Biology Physics. 71: 132-138. PMID 18037581 DOI: 10.1016/J.Ijrobp.2007.09.048 |
0.36 |
|
| 2008 |
Dehing-Oberije C, Ruysscher DD, Weide Hvd, Hochstenbag M, Bootsma G, Geraedts W, Pitz C, Simons J, Teule J, Rahmy A, Thimister P, Steck H, Lambin P. Tumor Volume Combined With Number Of Positive Lymph Node Stations Is A More Important Prognostic Factor Than Tnm Stage For Survival Of Non-Small-Cell Lung Cancer Patients Treated With (Chemo)Radiotherapy International Journal of Radiation Oncology Biology Physics. 70: 1039-1044. PMID 17889446 DOI: 10.1016/J.Ijrobp.2007.07.2323 |
0.385 |
|
| 2007 |
Bosmans G, Baardwijk AV, Dekker A, Ollers M, Wanders S, Boersma L, Lambin P, Ruysscher DD. Time Trends in Nodal Volumes and Motion During Radiotherapy for Patients With Stage III Non-Small-Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 71: 139-144. PMID 17996384 DOI: 10.1016/J.Ijrobp.2007.08.071 |
0.312 |
|
| 2007 |
Orban de Xivry J, Janssens G, Bosmans G, De Craene M, Dekker A, Buijsen J, van Baardwijk A, De Ruysscher D, Macq B, Lambin P. Tumour delineation and cumulative dose computation in radiotherapy based on deformable registration of respiratory correlated CT images of lung cancer patients Radiotherapy and Oncology. 85: 232-238. PMID 17936388 DOI: 10.1016/J.Radonc.2007.08.012 |
0.336 |
|
| 2007 |
Pijls-Johannesma M, Ruysscher DD, Vansteenkiste J, Kester A, Rutten I, Lambin P. Timing of chest radiotherapy in patients with limited stage small cell lung cancer : A systematic review and meta-analysis of randomised controlled trials Cancer Treatment Reviews. 33: 461-473. PMID 17513057 DOI: 10.1016/J.Ctrv.2007.03.002 |
0.359 |
|
| 2007 |
van Baardwijk A, Dooms C, van Suylen RJ, Verbeken E, Hochstenbag M, Dehing-Oberije C, Rupa D, Pastorekova S, Stroobants S, Buell U, Lambin P, Vansteenkiste J, De Ruysscher D. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. European Journal of Cancer (Oxford, England : 1990). 43: 1392-8. PMID 17512190 DOI: 10.1016/J.Ejca.2007.03.027 |
0.323 |
|
| 2007 |
Baardwijk Av, Bosmans G, Boersma L, Buijsen J, Wanders S, Hochstenbag M, Suylen Rv, Dekker A, Dehing-Oberije C, Houben R, Bentzen SM, Kroonenburgh Mv, Lambin P, Ruysscher DD. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. International Journal of Radiation Oncology Biology Physics. 68: 771-778. PMID 17398018 DOI: 10.1016/J.Ijrobp.2006.12.067 |
0.347 |
|
| 2007 |
Dagnelie PC, Pijls-Johannesma MCG, Lambin P, Beijer S, Ruysscher DD, Kempen GIJM. Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy Annals of Oncology. 18: 940-944. PMID 17363839 DOI: 10.1093/Annonc/Mdm057 |
0.314 |
|
| 2007 |
Baardwijk Av, Bosmans G, Dekker A, Kroonenburgh Mv, Boersma L, Wanders S, Öllers M, Houben R, Minken A, Lambin P, Ruysscher DD. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients Radiotherapy and Oncology. 82: 145-152. PMID 17258339 DOI: 10.1016/J.Radonc.2007.01.007 |
0.368 |
|
| 2007 |
Weppler SA, Krause M, Zyromska A, Lambin P, Baumann M, Wouters BG. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis. Radiotherapy and Oncology. 82: 96-104. PMID 17161482 DOI: 10.1016/J.Radonc.2006.11.004 |
0.321 |
|
| 2007 |
Mul VEM, Geest AJv, Pijls-Johannesma MCG, Theys J, Verschueren TAM, Jager JJ, Lambin P, Baumert BG. Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect. Radiotherapy and Oncology. 82: 5-9. PMID 17161479 DOI: 10.1016/J.Radonc.2006.11.014 |
0.322 |
|
| 2007 |
Baardwijk Av, Wanders R, Boersma L, Dingemans A, Bootsma G, Geraedts W, Pitz C, Simons J, Lambin P, Ruysscher DD. P3-046: Personalized High-Dose Continuous Hyperfractionated Accelerated Radiotherapy (HI-CHART) of non-small cell lung cancer (NSCLC) based on normal tissue constraints: a prospective clinical trial Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283803.40306.60 |
0.339 |
|
| 2007 |
Loon JV, Wanders R, Dekker A, Hochstenbag M, Bootsma G, Wiel G, Pitz C, Simons J, Lambin P, Ruysscher DD. PD6-1-8: 18-FDG-PET based planning of limited stage small cell lung cancer changes radiotherapy fields: A planning study Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283330.21602.Bf |
0.316 |
|
| 2007 |
Bosmans G, Aerts HJ, Baardwijk Av, Dekker A, Wanders S, Boersma L, Lambin P, Ruysscher DD. D7-05: FDG-PET allows identification of radioresistant areas within the tumor during and after radiation treatment of NSCLC Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283296.10960.Ac |
0.321 |
|
| 2007 |
Starmans MH, Krisnapuram B, Steck H, Seigneuric R, Buffa FM, Harris AL, Ruysscher DD, Wouters BG, Lambin P. D6-03: Proliferation and ‘invasiveness’ gene-expression signatures predict survival of surgically treated non-small-cell lung cancer Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283287.58693.11 |
0.305 |
|
| 2007 |
Dehing-Oberije C, Ruysscher DD, Weide Hvd, Hochstenbag M, Geraedts W, Pitz C, Simons J, Bootsma G, Steck H, Lambin P. A2-03: The combination of total tumor volume, number of positive lymph node stations on PET, gender, performance status and radiation dose is the best predictor for survival in patients with inoperable NSCLC, stage I-IIIB, treated with (chemo)radiation Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283099.09397.62 |
0.333 |
|
| 2007 |
Bosmans G, Baardwijk Av, Dekker A, Wanders S, Boersma L, Lambin P, Ruysscher DD. PD5-1-7: Time trends in nodal CT volume and nodal motion during radiotherapy for patients with stage III non-small cell lung cancer Journal of Thoracic Oncology. 2. DOI: 10.1016/j.ijrobp.2007.07.1699 |
0.322 |
|
| 2006 |
Bosmans G, Baardwijk Av, Dekker A, Öllers M, Boersma L, Minken A, Lambin P, Ruysscher DD. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: A prospective clinical study International Journal of Radiation Oncology Biology Physics. 66: 748-753. PMID 17011450 DOI: 10.1016/J.Ijrobp.2006.05.022 |
0.369 |
|
| 2006 |
De Ruysscher D, Bremer RH, Koppe F, Wanders S, van Haren E, Hochstenbag M, Geeraedts W, Pitz C, Simons J, ten Velde G, Dohmen J, Snoep G, Boersma L, Verschueren T, van Baardwijk A, ... ... Lambin P, et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 80: 307-12. PMID 16949169 DOI: 10.1016/J.Radonc.2006.07.029 |
0.334 |
|
| 2006 |
Duisters C, Beurskens H, Nijsten S, Starmans M, Wanders S, Verschueren T, Lambin P, Minken A, Ruysscher DD. Palliative chest irradiation in sitting position in patients with bulky advanced lung cancer. Radiotherapy and Oncology. 79: 285-287. PMID 16730089 DOI: 10.1016/J.Radonc.2006.05.003 |
0.313 |
|
| 2006 |
Dagnelie PC, Pijls-Johannesma MCG, Pijpe A, Boumans BJE, Skrabanja ATP, Lambin P, Kempen GIJM. Psychometric properties of the revised Piper Fatigue Scale in Dutch cancer patients were satisfactory Journal of Clinical Epidemiology. 59: 642-649. PMID 16713528 DOI: 10.1016/J.Jclinepi.2005.09.015 |
0.322 |
|
| 2006 |
Baardwijk Av, Baumert BG, Bosmans G, Kroonenburgh Mv, Stroobants S, Gregoire V, Lambin P, Ruysscher DD. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treatment Reviews. 32: 245-260. PMID 16563636 DOI: 10.1016/J.Ctrv.2006.02.002 |
0.336 |
|
| 2006 |
Ruysscher DD, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, Hochstenbag M, Boersma L, Wouters B, Lammering G, Vansteenkiste J, Lambin P. Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer Journal of Clinical Oncology. 24: 1057-1063. PMID 16505424 DOI: 10.1200/Jco.2005.02.9793 |
0.363 |
|
| 2006 |
Ruysscher DD, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Annals of Oncology. 17: 543-552. PMID 16344277 DOI: 10.1093/Annonc/Mdj094 |
0.348 |
|
| 2006 |
Baardwijk Av, Dooms C, Suylen Rv, Verbeken E, Hochstenbach M, Stroobants S, Buell U, Lambin P, Vansteenkiste J, Ruysscher DD. The maximum uptake of F-18-deoxyglucose on PET scan correlates with survival and two endogenous markers of hypoxia (Hypoxia Inducible Factor-alpha and Carbonic Anhydrase IX) in non-small cell lung cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.1347 |
0.322 |
|
| 2006 |
Baardwijk Av, Bosmans G, Dekker A, Kroonenburgh Mv, Boersma L, Wanders S, Oellers M, Minken A, Lambin P, Ruysscher DD. 44: Time Trends in the Maximal Uptake of FDG on PET Scan During Thoracic Radiotherapy. A Prospective Study in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.1343 |
0.357 |
|
| 2005 |
Bosmans G, Buijsen J, Dekker A, Velders M, Boersma L, Ruysscher DD, Minken A, Lambin P. An "in silico" clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients. Radiotherapy and Oncology. 81: 73-80. PMID 16971010 DOI: 10.1016/J.Radonc.2006.08.009 |
0.328 |
|
| 2005 |
Lussanet QGd, Backes WH, Griffioen AW, Padhani AR, Baeten CI, Baardwijk Av, Lambin P, Beets GL, Engelshoven JMAv, Beets-Tan RGH. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer International Journal of Radiation Oncology Biology Physics. 63: 1309-1315. PMID 16125874 DOI: 10.1016/J.Ijrobp.2005.04.052 |
0.33 |
|
| 2005 |
Ruysscher DD, Wanders S, Minken A, Lumens A, Schiffelers J, Stultiens C, Halders S, Boersma L, Baardwijk Av, Verschueren T, Hochstenbag M, Snoep G, Wouters B, Nijsten S, Bentzen SM, ... ... Lambin P, et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiotherapy and Oncology. 77: 5-10. PMID 16019093 DOI: 10.1016/J.Radonc.2005.06.014 |
0.346 |
|
| 2005 |
Ruysscher DD, Wanders S, Haren Ev, Hochstenbag M, Geeraedts W, Utama I, Simons J, Dohmen J, Rhami A, Buell U, Thimister P, Snoep G, Boersma L, Verschueren T, Baardwijk Av, ... ... Lambin P, et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. International Journal of Radiation Oncology Biology Physics. 62: 988-994. PMID 15989999 DOI: 10.1016/J.Ijrobp.2004.12.019 |
0.366 |
|
| 2005 |
Barbé S, Mellaert LV, Theys J, Geukens N, Lammertyn E, Lambin P, Anné J. Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment. Fems Microbiology Letters. 246: 67-73. PMID 15869963 DOI: 10.1016/J.Femsle.2005.03.037 |
0.307 |
|
| 2005 |
Wel AvD, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, Ruysscher DD. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. International Journal of Radiation Oncology Biology Physics. 61: 649-655. PMID 15708242 DOI: 10.1016/J.Ijrobp.2004.06.205 |
0.337 |
|
| 2005 |
Ruysscher DD, Pijls M, Bentzen S, Minken A, Wanders S, Hochstenbag M, Vansteenkiste J, Wouters B, Boersma L, Lambin P. P-758 SER, a novel time factor predictive for long-term survival in patients with limited disease small cell lung cancer after combined chest radiotherapy and chemotherapy Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)81251-6 |
0.334 |
|
| 2005 |
Ruysscher DD, Wanders S, Haren Ev, Hochstenbag M, Pitz C, Geraedts W, Simons J, Snoep G, Velde Gt, Lambin P. P-757 Omission of elective mediastinal node irradiation on basis ofCT-scans in patients with limited disease small cell lung cancer results in low isolated nodal failures: A phase II trial Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)81250-4 |
0.312 |
|
| 2005 |
Ruysscher DD, Wanders S, Minken A, Boersma L, Baardwijk Av, Hochstenbag M, Bentzen S, Snoep G, Kroonenburgh Mv, Lambin P. O-146 Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80280-6 |
0.358 |
|
| 2004 |
Pijls-Johannesma M, Ruysscher DKMD, Lambin P, Houben R, Rutten I, Vansteenkiste JF. Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer Cochrane Database of Systematic Reviews. CD004700. PMID 15674960 DOI: 10.1002/14651858.Cd004700.Pub2 |
0.371 |
|
| 2004 |
Bussels B, Maes A, Flamen P, Lambin P, Erven K, Hermans R, Nuyts S, Weltens C, Cecere S, Lesaffre E, Bogaert WVd. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiotherapy and Oncology. 73: 297-306. PMID 15588874 DOI: 10.1016/J.Radonc.2004.09.015 |
0.337 |
|
| 2004 |
Lutgens LCHW, Deutz N, Granzier-Peeters M, Beets-Tan RGH, Ruysscher DKMd, Gueulette J, Cleutjens JPM, Berger MPF, Wouters BG, Meyenfeldt MFv, Lambin P. Plasma citrulline concentration: A surrogate end point for radiation-induced mucosal atrophy of the small bowel. A feasibility study in 23 patients International Journal of Radiation Oncology Biology Physics. 60: 275-285. PMID 15337566 DOI: 10.1016/J.Ijrobp.2004.02.052 |
0.326 |
|
| 2004 |
Wouters BG, Beucken Tvd, Magagnin MG, Lambin P, Koumenis C. Targeting hypoxia tolerance in cancer Drug Resistance Updates. 7: 25-40. PMID 15072769 DOI: 10.1016/J.Drup.2003.12.004 |
0.319 |
|
| 2003 |
Hermans R, Meijerink M, Bogaert WVd, Rijnders A, Weltens C, Lambin P. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. International Journal of Radiation Oncology Biology Physics. 57: 1351-1356. PMID 14630273 DOI: 10.1016/S0360-3016(03)00764-8 |
0.358 |
|
| 2003 |
Lutgens LCHW, Deutz NEP, Gueulette J, Cleutjens JPM, Berger MPF, Wouters BG, Meyenfeldt MFv, Lambin P. Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage International Journal of Radiation Oncology Biology Physics. 57: 1067-1074. PMID 14575838 DOI: 10.1016/S0360-3016(03)00781-8 |
0.302 |
|
| 2003 |
Bloemen-van Gurp E, du Bois W, Visser P, Bruinvis I, Jalink D, Hermans J, Lambin P. Clinical dosimetry with MOSFET dosimeters to determine the dose along the field junction in a split beam technique. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 67: 351-7. PMID 12865186 DOI: 10.1016/S0167-8140(03)00035-5 |
0.307 |
|
| 2003 |
Langendijk H, Jong Jd, Wanders R, Lambin P, Slotman B. The importance of pre-treatment haemoglobin level in inoperable non-small cell lung carcinoma treated with radical radiotherapy. Radiotherapy and Oncology. 67: 321-325. PMID 12865181 DOI: 10.1016/S0167-8140(03)00057-4 |
0.335 |
|
| 2002 |
Stellamans K, Lievens Y, Lambin P, Weyngaert DVd, Bogaert WVd, Scalliet P, Hutsebaut L, Haustermans K. Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial Radiotherapy and Oncology. 65: 105-108. PMID 12443806 DOI: 10.1016/S0167-8140(02)00281-5 |
0.31 |
|
| 2002 |
Basha G, Landuyt W, Fowler J, Vordermark D, Haustermans K, Geboes K, Van Den Bogaert W, Yap SH, Lambin P, Penninckx F. An experimental evaluation of three preoperative radiation regimens for resectable rectal cancer Annals of Surgical Oncology. 9: 292-297. PMID 11923137 DOI: 10.1007/Bf02573068 |
0.32 |
|
| 2002 |
Wouters BG, Weppler SA, Koritzinsky M, Landuyt W, Nuyts S, Theys J, Chiu RK, Lambin P. Hypoxia as a target for combined modality treatments. European Journal of Cancer (Oxford, England : 1990). 38: 240-57. PMID 11803141 DOI: 10.1016/S0959-8049(01)00361-6 |
0.31 |
|
| 2002 |
Maes A, Weltens C, Flamen P, Lambin P, Bogaerts R, Liu X, Baetens J, Hermans R, Bogaert WVd. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiotherapy and Oncology. 63: 203-211. DOI: 10.1016/S0167-8140(02)00013-0 |
0.311 |
|
| 2001 |
Van Acker F, Flamen P, Lambin P, Maes A, Kutcher GJ, Weltens C, Hermans R, Baetens J, Dupont P, Rijnders A, Van Den Bogaert W, Mortelmans L. The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy Nuclear Medicine Communications. 22: 225-231. PMID 11258410 DOI: 10.1097/00006231-200102000-00015 |
0.307 |
|
| 2001 |
Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. International Journal of Radiation Oncology, Biology, Physics. 49: 379-89. PMID 11173131 DOI: 10.1016/S0360-3016(00)01471-1 |
0.3 |
|
| 1999 |
Hermans R, Lambin P, Goten AVd, Bogaert WVd, Verbist B, Weltens C, Delaere PR. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiotherapy and Oncology. 53: 105-111. PMID 10665786 DOI: 10.1016/S0167-8140(99)00132-2 |
0.313 |
|
| 1999 |
Joiner MC, Lambin P, Marples B. Adaptive response and induced resistance Comptes Rendus De L'Academie Des Sciences - Serie Iii. 322: 167-175. PMID 10196669 DOI: 10.1016/S0764-4469(99)80040-7 |
0.31 |
|
| 1998 |
Lambin P, Kramar A, Haie-Meder C, Castaigne D, Scalliet P, Bouzy J, Malaise E, Gerbaulet A. Tumour size in cancer of the cervix. Acta Oncologica. 37: 729-734. PMID 10050994 DOI: 10.1080/028418698430115 |
0.307 |
|
| 1997 |
Hermans R, Lambin P, Bogaert WVd, Haustermans K, Goten AVd, Baert AL. Non-invasive tumour perfusion measurement by dynamic CT: preliminary results Radiotherapy and Oncology. 44: 159-162. PMID 9288844 DOI: 10.1016/S0167-8140(97)01913-0 |
0.304 |
|
| 1996 |
Lievens Y, Haustermans K, Weyngaert DVd, Bogaert WVd, Scalliet P, Hutsebaut L, Fowler J, Lambin P. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial Radiotherapy and Oncology. 47: 149-153. PMID 9683362 DOI: 10.1016/S0167-8140(97)00231-4 |
0.33 |
|
| 1994 |
Lambin P, Gerbaulet A, Kramar A, Scalliet P, Haie-Meder C, Michel G, Parde M, Bouzy J, Malaise EP, Chassagne D. A comparison of early effects with two dose rates in brachytherapy of cervix carcinoma in a prospective randomised trial European Journal of Cancer. 30: 312-320. PMID 8204351 DOI: 10.1016/0959-8049(94)90248-8 |
0.313 |
|
| 1994 |
Haie-Meder C, Kramar A, Lambin P, Lancar R, Scalliet P, Bouzy J, Gerbaulet A. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. International Journal of Radiation Oncology Biology Physics. 29: 953-960. PMID 8083096 DOI: 10.1016/0360-3016(94)90388-3 |
0.314 |
|
| 1993 |
Lambin P, Gerbaulet A, Kramar A, Scalliet P, Haie-Meder C, Malaise E, Chassagne D. Phase III trial comparing two low dose rates in brachytherapy of cervix carcinoma: report at two years. International Journal of Radiation Oncology Biology Physics. 25: 405-412. PMID 8436517 DOI: 10.1016/0360-3016(93)90060-9 |
0.338 |
|
| 1993 |
Haie-Meder C, Kramar A, Lambin P, Lancar R, Scalliet P, Bouzy J, Gerbaulet A. Analysis of late effects of a randomized trial comparing two low dose rates in cervix cancer brachytherapy International Journal of Radiation Oncology Biology Physics. 27: 130. DOI: 10.1016/0360-3016(93)90634-8 |
0.305 |
|
| Show low-probability matches. |